Search

Your search keyword '"Sheibani, K"' showing total 201 results
Start Over Author "Sheibani, K" Language english
201 results on '"Sheibani, K"'

1. Visual acuity, endothelial cell density and polymegathism after iris-fixated lens implantation

Author

Nassiri N, Ghorbanhosseini S, Jafarzadehpur E, Kavousnezhad S, and Sheibani K

Subjects
Cornea, endothelial cell, density, Artiflex, refractive surgery., Ophthalmology, RE1-994
Abstract

Nader Nassiri,1 Saeedeh Ghorbanhosseini,2 Ebrahim Jafarzadehpur,2 Sara Kavousnezhad,3 Nariman Nassiri,4 Kourosh Sheibani5 1Imam Hossein Medical Center, Shahid Beheshti University of Medical Science, Tehran, Iran; 2Department of Optometry, Iran University of Medical Sciences, Tehran, Iran; 3Vanak Eye Clinic, Tehran, Iran; 4Jules Stein Eye Institute, University of California at Los Angeles, Los Angeles, CA, USA; 5Basir Eye Health Research Center, Basir Eye Clinic, Tehran, Iran Purpose: The purpose of this study was to evaluate the visual acuity as well as endothelial cell density (ECD) and polymegathism after iris-fixated lens (Artiflex® AC 401) implantation for correction of moderate to high myopia.Patients and methods: In this retrospective cross-sectional study, 55 eyes from 29 patients undergoing iris-fixated lens implantation for correction of myopia (−5.00 to −15.00 D) from 2007 to 2014 were evaluated. Uncorrected visual acuity, best spectacle-corrected visual acuity, refraction, ECD and polymegathism (coefficient of variation [CV] in the sizes of endothelial cells) were measured preoperatively and 6 months postoperatively.Results: In the sixth month of follow-up, the uncorrected vision acuity was 20/25 or better in 81.5% of the eyes. The best-corrected visual acuity was 20/30 or better in 96.3% of the eyes, and more than 92% of the eyes had a refraction score of ±1 D from the target refraction. The mean corneal ECD of patients before surgery was 2,803±339 cells/mm2, which changed to 2,744±369 cells/mm2 six months after surgery (p=0.142). CV in the sizes of endothelial cells before the surgery was 25.7%±7.1% and six months after surgery it was 25.9%±5.4% (p=0.857).Conclusion: Artiflex iris-fixated lens implantation is a suitable and predictable method for correction of moderate to high myopia. There was no statistically significant change in ECD and polymegathism (CV in the sizes of endothelial cells) after 6 months of follow-up. Keywords: cornea, endothelial cell, density, Artiflex, refractive surgery

Published
2018

3. A Case of Concurrent Proteus Syndrome and Hemophilia A

Author

Mozhgan Hashemieh, Mansoori, B., Tavakoli, R., and Sheibani, K.

Subjects
Musculoskeletal, Proteus syndrome, Case Report, Hemophilia A
Abstract

Background Proteus syndrome is a very rare condition with less than 100 confirmed cases reported worldwide. We report a case of Proteus syndrome in a two-year-old male who has hemophilia A comorbidity. Case Presentation A two-year-old male patient was admitted with the chief complaint of severe bleeding in mouth cavity after trauma for two weeks. At admission he was found to have petechiae on buccal mucosa and fecal discoloration due to GI bleeding. We noted multiple abnormalities in his musculoskeletal system and skin. He had lymph edema in left leg, hemihypertrophy, macrodactyly in both foots and macrocephaly. With the history of severe bleeding and recurrent blood product transfusion, we suspected a hemorrhagic disorder. The reduced level of Factor VIII activity confirmed the diagnosis of hemophilia A. Considering patient's various musculoskeletal abnormalities according to the diagnostic criteria and after ruling out similar disorders the diagnosis of Proteus syndrome was established. Conclusion Because of the variability of clinical features, Proteus syndrome can be confused with other disorders of multiple tissue overgrowth. Our case of Proteus syndrome, who had hemophilia A comorbidity outlines the challenges in diagnosis of such rare combination of diseases.

Published
2012

4. Electrocardiographic Changes After Granisetron Administration for Chemotherapy Induced Nausea and Vomiting

Author

Alidoosti, A., Taslimi, F., Ameri, A., Sheibani, K. M., reza miri, and Yavari, P.

Subjects
Electrocardiography, lcsh:R5-920, cardiovascular diseases, chemotherapy, lcsh:Medicine (General), Granisetron
Abstract

Cancer patient receive various cytotoxic drugs in association with antiemetic drugs such as 5HT3 receptor antagonists as their chemotherapy regimen. 5HT3 receptor antagonists have been reported to produce changes in ECG parameter. There are only a few studies about cardiovascular events of these drugs in patient receiving potentially cardiotoxic chemotherapies. The subject of this study is to evaluate ECG changes after administration of chemotherapeutic agents and granisetron (the most commonly used 5HT3 antagonist in Iran) in adults with cancer. For this clinical trial study, all cancer patients referred to department of radiation oncology of Imam Hossein Hospital since August 2005 to March 2006 were evaluated if they had inclusion criteria. Granisetron (3 mg) was infused intravenously over 30 seconds just a few minutes before chemotherapeutic agent administration. The 12-lead ECG recording was obtained before and 90 minutes after infusion of granisetron. One cardiologist determined PR, QRS, QTc intervals and heart rate of all ECGs. During the study period 54 patients fulfilled our criteria. With paired t-test, the PR and QTc intervals, but not QRS interval showed statistically significant prolongation after drug infusion (P < 0.0001), and heart rate showed statistically significant decrease (P < 0.0001). The ECG findings of chemotherapeutic agents and granisetron administration were prolongation of PR and QTc intervals and decrease of heart rate (P < 0.0001). Although these changes did not cause clinical signs, with keeping in mind that there may be possible drug-drug interactions and preexisting cardiac comorbidities in cancer patient, it seems reasonable and necessary to consider physical condition specifically cardiac condition and drug usage of each patient, while designing chemotherapy regimen and supportive drugs.

Published
2009

5. The intermediary role of self-efficacy in relation with stress, glycosylated haemoglobin and health-related quality of life in patients with type2 diabetes

Author

Alipour, A., Zare, H., hamid poursharifi, Aerab Sheibani, K., and Afkhami Ardekani, M.

Subjects
Self efficacy, HbA1c, Health-related quality, lcsh:Public aspects of medicine, Diabetes, lcsh:RA1-1270, Stress
Abstract

Background: Stress is not always a direct result of stressful conditions, but rather the way they are perceived. Thus individual variables that may be associated with perceived stress should be examined in stress studies. This study investigates the intermediary role of self-efficacy in relation with stress, glycosylated haemoglobin and health-related quality of life in patients with type2 diabetes.Methods: All women with diabetes in Yazd Diabetes Research Centre, in 2012, were considered and 80 women were selected by random sampling. They completed Shirer’s self-efficacy scale questionnaire, depression, anxiety and stress scale (DASS), and ADDQ0L19 questionnaire. Then they were introduced to the lab for blood test. Data were analysed by SPSS software and stepwise regression method.Results: Pearson correlation test results showed that the hemoglobin A1c (r = 0.35) and Quality of Life (r = -0.22) are associated with stress (P

Published
2012

6. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets

Author

Ben-Ezra, J., Sheibani, K., Hwang, D. L., and Lev-Ran, A.

Subjects
Blood Platelets, Base Sequence, Epidermal Growth Factor, Cell Membrane, Molecular Sequence Data, Polyethylene Glycols, Immunoenzyme Techniques, Bone Marrow, Frozen Sections, Humans, Insulin, RNA, Messenger, Oligonucleotide Probes, Megakaryocytes, hormones, hormone substitutes, and hormone antagonists, Research Article
Abstract

Epidermal growth factor (EGF) is known to be present in the alpha granules of human platelets; however the source of this EGF, ie, whether it is taken up by the platelets from the circulation, or whether it is packaged into the platelets from the megakaryocyte during thrombopoiesis, is unknown. To determine whether EGF is taken up by platelets, platelets for EGF receptors were assayed and it was attempted to detect uptake of EGF by the platelets from culture medium. Platelets were found to lack EGF receptors, and no uptake of EGF from the culture medium was detected. To assess whether EGF is packaged into platelets from the megakaryocyte, megakaryocytes in frozen section bone marrow cores were stained for EGF protein by immunohistochemistry, and it was demonstrated that EGF is present in megakaryocytes. In addition, staining of megakaryocytes by in situ hybridization for EGF mRNA demonstrated its presence in these cells. Therefore it is concluded that the source of EGF in human platelets is the megakaryocyte and that this EGF is synthesized in the megakaryocyte rather than being taken up from its environment.

Published
1990

9. Relation between serum ferritin and liver and heart MRI T2* in beta thalassaemia major patients.

Author

Azarkeivan, A., Hashemieh, M., Akhlaghpoor, S., Shirkavand, A., Yaseri, M., and Sheibani, K.

Abstract

There is a need for highly accurate non-invasive methods for assessing organ iron content in thalassaemia patients. This study evaluated the relation between serum ferritin level, liver enzyme levels and hepatitis C antibody and liver and heart iron deposition assessed by MRI T2*. Data were obtained from the medical records of 156 thalassemia major patients in Tehran. There was a moderate negative correlation between serum ferritin and liver MRI T2* relaxation time (r = -0.535) and a weak negative correlation between serum ferritin and heart MRI T2* relaxation time (r = -0.361). Hepatitis C infection and liver enzyme levels did not confound or modify the relation between ferritin and liver or heart MRI T2*. Liver and heart MRI T2* readings were poorly correlated (r = 0. 281). Routine evaluation of liver and heart iron content using MRI T2* is suggested to better evaluate the haemosiderosis status in thalassemia patients. [ABSTRACT FROM AUTHOR]

Published
2013

20. Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists. A comprehensive statistical analysis of interobserver performance.

Author

Sheibani, Khalil, Nathwani, Bharat N., Swartz, William G., Ben-Ezra, Jonathan, Brownell, Mark D., Burke, Jerome S., Kennedy, John L., Koo, Chae H., Winberg, Carl D., Sheibani, K, Nathwani, B N, Swartz, W G, Ben-Ezra, J, Brownell, M D, Burke, J S, Kennedy, J L, Koo, C H, and Winberg, C D

Published
1988
Full Text
View/download PDF

25. L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen

Author

Hsu, S. M., Ho, Y. S., Li, P. J., Monheit, J., Ree, H. J., Sheibani, K., and Winberg, C. D.

Subjects
Histocytochemistry, Neuraminidase, Histiocytes, Hodgkin Disease, N-Acetylneuraminic Acid, Immunoenzyme Techniques, stomatognathic system, immune system diseases, hemic and lymphatic diseases, Sialic Acids, Humans, Lymphocytes, Antigens, Research Article
Abstract

Anti-Leu M1 generally does not stain the lymphocytic and histiocytic (L&H) variants of Reed-Sternberg cells in the lymphocyte predominant type of Hodgkin's disease. However, the authors found that after neuraminidase treatment for removal of sialic acid, the L&H cells in more than half of the cases studied could be stained by anti-Leu M1. This result strongly suggests that L&H cells differ from the Reed-Sternberg cells in other types of Hodgkin's disease in their unique capacity to sialylate the 150-kd Leu M1 antigen.

Published
1986

26. Monocytoid B-cell lymphoma. A novel B-cell neoplasm

Author

Sheibani, K., Sohn, C. C., Burke, J. S., Winberg, C. D., Wu, A. M., and Rappaport, H.

Subjects
Male, B-Lymphocytes, Lymphoma, hemic and lymphatic diseases, Humans, Female, Middle Aged, Monocytes, Research Article, Aged
Abstract

Monocytoid B lymphocytes (MBLs), originally described as part of the histologic picture of toxoplasmic lymphadenitis, have been recognized as a reactive component in a variety of lymph node disorders. The authors now report 3 cases of non-Hodgkin's lymphoma in which a multidisciplinary approach allowed them to confirm the existence of a malignant lymphoma composed of the neoplastic counterpart of the MBLs found in nonneoplastic disorders. In all 3 cases, the lymphoma was composed of a relatively monomorphous infiltrate of atypical MBLs that had rather uniform-appearing nuclei and had well-defined, moderately abundant pale cytoplasm. The pattern of lymph node involvement in all 3 cases was predominantly sinusoidal and interfollicular. The neoplastic lymphoid cells were strongly positive for B-cell-restricted antigens; the light- and heavy-chain phenotypes were kappa-IgM (2 cases) and kappa-IgG (1 case). In all 3 cases, rearrangement of heavy- and/or light-chain genes was clearly identified by Southern blot hybridization. The name "monocytoid B-cell lymphoma" is proposed for this newly described malignant B-cell neoplasm.

Published
1986

28. A lost pigtail.

Author

Cosset, J M, Sharp, C, Clough, K, and Sheibani, K M

Published
1999

29. Unveiling the strong interaction among hadrons at the LHC

Author

Acharya, Shreyasi, Adamova, Dagmar, Ahn, Sang Un, Bhattacharjee, Buddhadeb, Yurchenko, Volodymyr, Zaccolo, Valentina, Zaman, Ali, Zampolli, Chiara, Correia Zanoli, Henrique Jose, Zardoshti, Nima, Zarochentsev, Andrey, Zavada, Petr, Zavyalov, Nikolay, Zbroszczyk, Hanna Paulina, Bianchi, Antonio, Zhalov, Mikhail, Zhang, Song, Zhang, Xiaoming, Zhang, Zuman, Zherebchevskii, Vladimir, Yu, Zhi, Zhou, Daicui, Zhou, You, Zhou, Zhuo, Zhu, Jianhui, Bianchi, Livio, Zhu, Ya, Zichichi, Antonino, Zinovjev, Gennady, Zurlo, Nicola, ALICE Collaboration, Bianchi, Nicola, Bielcik, Jaroslav, Bielcikova, Jana, Bilandzic, Ante, Biro, Gabor, Biswas, Rathijit, Biswas, Saikat, Akbar, Zaenal, Blair, Justin Thomas, Blau, Dmitry, Blume, Christoph, Boca, Gianluigi, Bock, Friederike, Bogdanov, Alexey, Boi, Stefano, Bok, Jeongsu, Boldizsar, Laszlo, Bolozdynya, Alexander, Akindinov, Alexander, Bombara, Marek, Bonomi, Germano, Borel, Herve, Borissov, Alexander, Bossi, Hannah, Botta, Elena, Bratrud, Lars, Braun-munzinger, Peter, Bregant, Marco, Broz, Michal, Al-turany, Mohammad, Bruna, Elena, Bruno, Giuseppe Eugenio, Buckland, Matthew Daniel, Budnikov, Dmitry, Buesching, Henner, Bufalino, Stefania, Bugnon, Ophelie, Buhler, Paul Alois, Buncic, Predrag, Buthelezi, Edith Zinhle, Alam, Sk Noor, Bashir Butt, Jamila, Bysiak, Sebastian Adam, Caffarri, Davide, Caliva, Alberto, Calvo Villar, Ernesto, Mejia Camacho, Juan Manuel, Soto Camacho, Rabi, Camerini, Paolo, De Moraes Canedo, Fabio, Capon, Aaron Allan, Silva De Albuquerque, Danilo, Carnesecchi, Francesca, Caron, Robin Albert Andre, Castillo Castellanos, Javier Ernesto, Castro, Andrew John, Casula, Ester Anna Rita, Catalano, Fabio, Ceballos Sanchez, Cesar, Chakraborty, Pritam, Chandra, Sinjini, Chang, Wan, Aleksandrov, Dmitry, Chapeland, Sylvain, Chartier, Marielle, Chattopadhyay, Subhasis, Chattopadhyay, Sukalyan, Chauvin, Alex Henri Jean, Cheshkov, Cvetan Valeriev, Cheynis, Brigitte, Chibante Barroso, Vasco Miguel, Dobrigkeit Chinellato, David, Cho, Soyeon, Alessandro, Bruno, Chochula, Peter, Chowdhury, Tasnuva, Christakoglou, Panagiotis, Christensen, Christian Holm, Christiansen, Peter, Chujo, Tatsuya, Cicalo, Corrado, Cifarelli, Luisa, De Cilladi, Lorenzo, Cindolo, Federico, Alfanda, Haidar Mas'ud, Ciupek, Michael Rudolf, Clai, Giulia, Cleymans, Jean Willy Andre, Colamaria, Fabio Filippo, Colella, Domenico, Collu, Alberto, Colocci, Manuel, Concas, Matteo, Conesa Balbastre, Gustavo, Conesa Del Valle, Zaida, Alfaro Molina, Jose Ruben, Contin, Giacomo, Contreras Nuno, Jesus Guillermo, Cormier, Thomas Michael, Corrales Morales, Yasser, Cortese, Pietro, Cosentino, Mauro Rogerio, Costa, Filippo, Costanza, Susanna, Crochet, Philippe, Cuautle Flores, Eleazar, Adler, Alexander, Ali, Bushra, Cui, Pengyao, Cunqueiro Mendez, Leticia, Dabrowski, Daniel, Dahms, Torsten, Dainese, Andrea, Damas, Florian Paul Andre, Danisch, Meike Charlotte, Danu, Andrea, Das, Debasish, Das, Indranil, Ali, Yasir, Das, Prottay, Das, Prottoy, Das, Supriya, Dash, Ajay Kumar, Dash, Sadhana, De, Sudipan, De Caro, Annalisa, De Cataldo, Giacinto, De Cuveland, Jan, De Falco, Alessandro, Alici, Andrea, De Gruttola, Daniele, De Marco, Nora, De Pasquale, Salvatore, Deb, Suman, Franz Degenhardt, Hermann, Deja, Kamil Rafal, Deloff, Andrzej, Delsanto, Silvia, Deng, Wenjing, Dhankher, Preeti, Alizadehvandchali, Negin, Di Bari, Domenico, Di Mauro, Antonio, Arteche Diaz, Raul, Dietel, Thomas, Raisig, Pascal, Ding, Yanchun, Divia, Roberto, Dixit, Dhruv Utpalkumar, Djuvsland, Oeystein, Dmitrieva, Uliana, Alkin, Anton, Dobrin, Alexandru Florin, Donigus, Benjamin, Dordic, Olja, Dubey, Anand Kumar, Dubla, Andrea, Dudi, Sandeep, Mallick, Dukhishyam, Dupieux, Pascal, Ehlers Iii, Raymond James, Eikeland, Viljar Nilsen, Alme, Johan, Elia, Domenico, Erazmus, Barbara Ewa, Erhardt, Filip, Erokhin, Andrey, Ersdal, Magnus Rentsch, Espagnon, Bruno, Eulisse, Giulio, Evans, David, Evdokimov, Sergey, Fabbietti, Laura, Alt, Torsten, Faggin, Mattia, Faivre, Julien, Fan, Feng, Fantoni, Alessandra, Fasel, Markus, Fecchio, Pietro, Feliciello, Alessandro, Feofilov, Grigorii, Fernandez Tellez, Arturo, Ferrero, Andrea, Altenkamper, Lucas, Ferretti, Alessandro, Festanti, Andrea, Feuillard, Victor Jose Gaston, Figiel, Jan, Filchagin, Sergey, Finogeev, Dmitry, Fionda, Fiorella, Fiorenza, Gabriele, Flor, Fernando Antonio, Flores, Amanda Nicole, Altsybeev, Igor, Foertsch, Siegfried Valentin, Foka, Panagiota, Fokin, Sergey, Fragiacomo, Enrico, Frankenfeld, Ulrich Michael, Fuchs, Ulrich, Furget, Christophe, Furs, Artur, Fusco Girard, Mario, Gaardhoeje, Jens Joergen, Anaam, Mustafa, Gagliardi, Martino, Gago Medina, Alberto Martin, Gal, Arthur Willem Jean, Duarte Galvan, Carlos, Ganoti, Paraskevi, Garabatos Cuadrado, Jose, Alvarado Garcia, Jesus Ricardo, Garcia-solis, Edmundo Javier, Garg, Kunal, Gargiulo, Corrado, Adolfsson, Jonatan, Andrei, Cristian, Garibli, Aydan, Garner, Katharina, Gasik, Piotr Jan, Gauger, Erin Frances, De Leone Gay, Maria Beatriz, Germain, Marie, Ghosh, Jhuma, Ghosh, Premomoy, Ghosh, Sanjay Kumar, Giacalone, Marco, Andreou, Dimitra, Gianotti, Paola, Giubellino, Paolo, Giubilato, Piero, Glaenzer, Aude Marie Camille, Glassel, Peter, Gomez Ramirez, Andres, Gonzalez, Victor, Gonzalez Trueba, Laura Helena, Gorbunov, Sergey, Gorlich, Lidia Maria, Andronic, Anton, Goswami, Ankita, Gotovac, Sven, Grabski, Varlen, Graczykowski, Lukasz Kamil, Graham, Katie Leanne, Greiner, Leo Clifford, Grelli, Alessandro, Grigoras, Costin, Grigoryev, Vladislav, Grigoryan, Ara, Angeletti, Massimo, Grigoryan, Smbat, Groettvik, Ola Slettevoll, Grosa, Fabrizio, Grosse-oetringhaus, Jan Fiete, Grosso, Raffaele, Guernane, Rachid, Guittiere, Manuel, Gulbrandsen, Kristjan Herlache, Gunji, Taku, Gupta, Anik, Anguelov, Venelin, Gupta, Ramni, Bautista Guzman, Irais, Haake, Rudiger, Habib, Michael Karim, Hadjidakis, Cynthia Marie, Hamagaki, Hideki, Hamar, Gergoe, Hamid, Mohammed, Hannigan, Ryan Patrick, Haque, Md Rihan, Anson, Christopher Daniel, Harlenderova, Alena, Harris, John William, Harton, Austin Vincent, Hasenbichler, Jan Anton, Hassan, Hadi, Hassan, Qamar Ul, Hatzifotiadou, Despina, Hauer, Philip, Havener, Laura Brittany, Hayashi, Shinichi, Anticic, Tome, Heckel, Stefan Thomas, Hellbar, Ernst, Helstrup, Haavard, Herghelegiu, Andrei Ionut, Herman, Tomas, Gonzalez Hernandez, Emma, Herrera Corral, Gerardo Antonio, Herrmann, Florian, Hetland, Kristin Fanebust, Hillemanns, Hartmut, Antinori, Federico, Hills, Christopher, Hippolyte, Boris, Hohlweger, Bernhard, Honermann, Jan, Horak, David, Hornung, Andrea, Hornung, Sebastian, Hosokawa, Ritsuya, Hristov, Peter Zahariev, Huang, Chun-lu, Antonioli, Pietro, Hughes, Charles, Huhn, Patrick, Humanic, Thomas, Hushnud, Hushnud, Husova, Lucia Anna, Hussain, Nur, Hussain, Syed Asad, Hutter, Dirk, Iddon, James Philip, Ilkaev, Radiy, Apadula, Nicole, Ilyas, Hira, Inaba, Motoi, Innocenti, Gian Michele, Ippolitov, Mikhail, Isakov, Artem, Islam, Md Samsul, Ivanov, Marian, Ivanov, Vladimir, Izucheev, Vladimir, Jacak, Barbara, Aggarwal, Madan Mohan, Aphecetche, Laurent Bernard, Jacazio, Nicolo, Jacobs, Peter Martin, Jadlovska, Slavka, Jadlovsky, Jan, Jaelani, Syaefudin, Jahnke, Cristiane, Jakubowska, Monika Joanna, Janik, Malgorzata Anna, Janson, Thomas, Jercic, Marko, Appelshaeuser, Harald, Jevons, Oliver Thomas, Jin, Muqing, Jonas, Florian, Jones, Peter Graham, Jung, Jerome, Jung, Michael, Jusko, Anton, Kalinak, Peter, Kalweit, Alexander Philipp, Kaplin, Vladimir, Arcelli, Silvia, Kar, Somnath, Karasu Uysal, Ayben, Karatovic, David, Karavichev, Oleg, Karavicheva, Tatiana, Karczmarczyk, Przemyslaw, Karpechev, Evgeny, Kazantsev, Andrey, Kebschull, Udo Wolfgang, Keidel, Ralf, Arnaldi, Roberta, Keil, Markus, Ketzer, Bernhard Franz, Khabanova, Zhanna, Khan, Ahsan Mehmood, Khan, Shaista, Khanzadeev, Alexei, Kharlov, Yury, Khatun, Anisa, Khuntia, Arvind, Kileng, Bjarte, Arratia Munoz, Miguel Ignacio, Kim, Beomkyu, Kim, Byungchul, Kim, Daehyeok, Kim, Dong Jo, Kim, Eun Joo, Kim, Hyeonjoong, Kim, Jaehyun, Kim, Jinsook, Kim, Jiyoung, Kim, Jungeol, Arsene, Ionut Cristian, Kim, Junlee, Kim, Minjung, Kim, Se Yong, Kim, Taejun, Kim, Taesoo, Kirsch, Stefan, Kisel, Ivan, Kiselev, Sergey, Kisiel, Adam Ryszard, Klay, Jennifer Lynn, Arslandok, Mesut, Klein, Carsten, Klein, Jochen, Klein, Spencer Robert, Klein-boesing, Christian, Kleiner, Matthias, Kluge, Alexander, Knichel, Michael Linus, Knospe, Anders Garritt, Kobdaj, Chinorat, Kohler, Markus Konrad, Augustinus, Andre, Kollegger, Thorsten Sven, Kondratyev, Andrey, Kondratyeva, Natalia, Kondratyuk, Evgeny, Konig, Joshua Leon, Konigstorfer, Stephan Alexander, Konopka, Piotr Jan, Kornakov, Georgui, Koska, Lukas, Kovalenko, Oleksandr, Averbeck, Ralf Peter, Kovalenko, Vladimir, Kowalski, Marek, Kralik, Ivan, Kravcakova, Adela, Kreis, Lukas, Krivda, Marian, Krizek, Filip, Krizkova Gajdosova, Katarina, Kruger, Mario, Kryshen, Evgeny, Aziz, Sizar, Krzewicki, Mikolaj, Kubera, Andrew Michael, Kucera, Vit, Kuhn, Christian Claude, Kuijer, Paulus Gerardus, Kumar, Lokesh, Kundu, Sourav, Kurashvili, Podist, Kurepin, Alexander, Kurepin, Alexey, Aglieri Rinella, Gianluca, Azmi, Mohd Danish, Kuryakin, Alexey, Kushpil, Svetlana, Kvapil, Jakub, Kweon, Min Jung, Kwon, Jiyeon, Kwon, Youngil, La Pointe, Sarah Louise, La Rocca, Paola, Lai, Yue Shi, Lamanna, Massimo, Badala, Angela, Langoy, Rune, Lapidus, Kirill, Lardeux, Antoine Xavier, Larionov, Pavel, Laudi, Elisa, Lavicka, Roman, Lazareva, Tatiana, Lea, Ramona, Leardini, Lucia, Lee, Joonil, Baek, Yongwook, Lee, Seongjoo, Lehner, Sebastian, Lehrbach, Johannes, Lemmon, Roy Crawford, Leon Monzon, Ildefonso, Lesser, Ezra Douglas, Lettrich, Michael, Levai, Peter, Li, Xiaomei, Li, Xing Long, Bagnasco, Stefano, Lien, Jorgen Andre, Lietava, Roman, Lim, Bong-hwi, Lindenstruth, Volker, Lindner, Amelia, Lippmann, Christian, Lisa, Michael Annan, Liu, Alwina Ruixin, Liu, Jian, Liu, Suyuan, Bai, Xiaozhi, Llope, William Joseph, Lofnes, Ingrid Mckibben, Loginov, Vitaly, Loizides, Constantinos, Loncar, Petra, Lopez Lopez, Jorge Andres, Lopez, Xavier Bernard, Lopez Torres, Ernesto, Luhder, Jens Robert, Lunardon, Marcello, Bailhache, Raphaelle Marie, Luparello, Grazia, Ma, Yugang, Maevskaya, Alla, Mager, Magnus, Mahmood, Sohail Musa, Mahmoud, Tariq, Maire, Antonin, Majka, Richard Daniel, Malaev, Mikhail, Malik, Qasim Waheed, Bala, Renu, Malinina, Liudmila, Mal Kevich, Dmitry, Malzacher, Peter, Mandaglio, Giuseppe, Manko, Vladislav, Manso, Franck, Manzari, Vito, Mao, Yaxian, Marchisone, Massimiliano, Mares, Jiri, Balbino, Alessandro, Margagliotti, Giacomo Vito, Margotti, Anselmo, Marin, Ana Maria, Markert, Christina, Marquard, Marco, De Martin, Chiara, Martin, Nicole Alice, Martinengo, Paolo, Martinez, Jacobb Lee, Martinez Hernandez, Mario Ivan, Baldisseri, Alberto, Martinez-garcia, Gines, Masciocchi, Silvia, Masera, Massimo, Masoni, Alberto, Massacrier, Laure Marie, Masson, Erwann, Mastroserio, Annalisa, Mathis, Andreas Michael, Matonoha, Oliver, Toledo Matuoka, Paula Fernanda, Ball, Markus, Matyja, Adam Tomasz, Mayer, Christoph, Mazzaschi, Francesco, Mazzilli, Marianna, Mazzoni, Alessandra Maria, Mechler, Adrian Florin, Meddi, Franco, Melikyan, Yury, Menchaca-rocha, Arturo Alejandro, Cai, Mengke, Agnello, Michelangelo, Balouza, Samah, Meninno, Elisa, Sasikumar Menon, Anjaly, Meres, Michal, Mhlanga, Sibaliso, Miake, Yasuo, Micheletti, Luca, Migliorin, Lucrezia Camilla, Mihaylov, Dimitar Lubomirov, Mikhaylov, Konstantin, Mishra, Aditya Nath, Banerjee, Debjani, Miskowiec, Dariusz Czeslaw, Modak, Abhi, Mohammadi, Naghmeh, Mohanty, Auro Prasad, Mohanty, Bedangadas, Khan, Mohammed Mohisin, Moravcova, Zuzana, Mordasini, Cindy, Moreira De Godoy, Denise Aparecida, Perez Moreno, Luis Alberto, Barbera, Roberto, Morozov, Igor, Morsch, Andreas, Mrnjavac, Teo, Muccifora, Valeria, Mudnic, Eugen, Muhlheim, Daniel Michael, Muhuri, Sanjib, Mulligan, James Declan, Mulliri, Alice, Gameiro Munhoz, Marcelo, Barioglio, Luca, Munzer, Robert Helmut, Murakami, Hikari, Murray, Sean, Musa, Luciano, Musinsky, Jan, Myers, Corey James, Myrcha, Julian Wojciech, Naik, Bharati, Nair, Rahul Ramachandran, Nandi, Basanta Kumar, Barnafoldi, Gergely Gabor, Nania, Rosario, Nappi, Eugenio, Naru, Muhammad Umair, Nassirpour, Adrian Fereydon, Nattrass, Christine, Nayak, Ranjit, Nayak, Tapan Kumar, Nazarenko, Sergey, Neagu, Alexandra, Negrao De Oliveira, Renato Aparecido, Barnby, Lee Stuart, Nellen, Lukas, Nesbo, Simon Voigt, Neskovic, Gvozden, Nesterov, Dmitrii, Neumann, Lukasz Tomasz, Nielsen, Borge Svane, Nikolaev, Sergey, Nikulin, Sergey, Nikulin, Vladimir, Noferini, Francesco, Ramillien Barret, Valerie, Nomokonov, Petr, Norman, Jaime, Novitzky, Norbert, Nowakowski, Piotr, Nyanin, Alexander, Nystrand, Joakim Ingemar, Ogino, Masanori, Ohlson, Alice Elisabeth, Oleniacz, Janusz, Oliveira Da Silva, Antonio Carlos, Bartalini, Paolo, Oliver, Michael Henry, Oppedisano, Chiara, Ortiz Velasquez, Antonio, Oskarsson, Anders Nils Erik, Otwinowski, Jacek Tomasz, Oyama, Ken, Pachmayer, Yvonne Chiara, Pacik, Vojtech, Padhan, Sonali, Pagano, Davide, Bartels, Clara, Paic, Guy, Pan, Jinjin, Panebianco, Stefano, Pareek, Pooja, Park, Jonghan, Parkkila, Jasper Elias, Parmar, Sonia, Pathak, Surya Prakash, Paul, Biswarup, Pazzini, Jacopo, Barth, Klaus, Pei, Hua, Peitzmann, Thomas, Peng, Xinye, Pereira, Luis Gustavo, Pereira Da Costa, Hugo Denis Antonio, Peresunko, Dmitry Yurevich, Mesa Perez, Guillermo, Perrin, Sebastien, Pestov, Yury, Petracek, Vojtech, Agrawal, Neelima, Bartsch, Esther, Petrovici, Mihai, Peretti Pezzi, Rafael, Piano, Stefano, Pikna, Miroslav, Pillot, Philippe, Pinazza, Ombretta, Pinsky, Lawrence, Pinto, Chiara, Pisano, Silvia, Pistone, Daniele, Baruffaldi, Filippo, Ploskon, Mateusz Andrzej, Planinic, Mirko, Pliquett, Fabian, Poghosyan, Martin, Polishchuk, Boris, Poljak, Nikola, Pop, Amalia, Porteboeuf, Sarah Julie, Pozdniakov, Valeriy, Prasad, Sidharth Kumar, Bastid, Nicole, Preghenella, Roberto, Prino, Francesco, Pruneau, Claude Andre, Pshenichnov, Igor, Puccio, Maximiliano, Putschke, Jorn Henning, Qiu, Shi, Quaglia, Luca, Quishpe Quishpe, Raquel Estefania, Ragoni, Simone, Basu, Sumit, Raha, Sibaji, Rajput, Sonia, Rak, Jan, Rakotozafindrabe, Andry Malala, Ramello, Luciano, Rami, Fouad, Rodriguez Ramirez, Saul Anibal, Raniwala, Rashmi, Raniwala, Sudhir, Rasanen, Sami Sakari, Batigne, Guillaume, Rath, Rutuparna, Ratza, Viktor, Ravasenga, Ivan, Read, Kenneth Francis, Redelbach, Andreas Ralph, Redlich, Krzysztof, Rehman, Attiq Ur, Reichelt, Patrick Simon, Reidt, Felix, Ren, Xiaowen, Batyunya, Boris, Renfordt, Rainer Arno Ernst, Jakubcinova, Zuzana, Reygers, Klaus Johannes, Riabov, Andrei, Riabov, Viktor, Richert, Tuva Ora Herenui, Richter, Matthias Rudolph, Riedler, Petra, Riegler, Werner, Riggi, Francesco, Bauri, Dibakar, Ristea, Catalin-lucian, Rode, Sudhir Pandurang, Rodriguez Cahuantzi, Mario, Roeed, Ketil, Rogalev, Roman, Rogochaya, Elena, Rohr, David Michael, Roehrich, Dieter, Fierro Rojas, Pablo, Rokita, Przemyslaw Stefan, Bazo Alba, Jose Luis, Ronchetti, Federico, Rosano, Antonina, Dominguez Rosas, Edgar, Roslon, Krystian, Rossi, Andrea, Rotondi, Alberto, Roy, Ankhi, Roy, Pradip Kumar, Vazquez Rueda, Omar, Rui, Rinaldo, Bearden, Ian Gardner, Rumyantsev, Boris, Rustamov, Anar, Ryabinkin, Evgeny, Ryabov, Yury, Rybicki, Andrzej, Rytkonen, Heidi Maria, Saarimaki, Oskari Antti Matti, Sadek, Rita, Sadhu, Samrangy, Sadovskiy, Sergey, Beattie, Caitlin, Safarik, Karel, Saha, Sumit Kumar, Sahoo, Baidyanath, Sahoo, Pragati, Sahoo, Raghunath, Sahoo, Sarita, Sahu, Pradip Kumar, Saini, Jogender, Sakai, Shingo, Sambyal, Sanjeev Singh, Ahammed, Zubayer, Bedda, Cristina, Samsonov, Vladimir, Sarkar, Debojit, Sarkar, Nachiketa, Sarma, Pranjal, Mantovani Sarti, Valentina, Sas, Mike Henry Petrus, Scapparone, Eugenio, Schambach, Johann Joachim, Scheid, Horst Sebastian, Schiaua, Claudiu Cornel, Behera, Nirbhay Kumar, Schicker, Rainer Martin, Schmah, Alexander, Schmidt, Christian Joachim, Schmidt, Hans Rudolf, Schmidt, Marten Ole, Schmidt, Martin, Schmidt, Nicolas, Schmier, Austin Robert, Schukraft, Jurgen, Schutz, Yves Roland, Belikov, Iouri, Schwarz, Kilian Eberhard, Schweda, Kai Oliver, Scioli, Gilda, Scomparin, Enrico, Seger, Janet Elizabeth, Sekiguchi, Yuko, Sekihata, Daiki, Selyuzhenkov, Ilya, Senyukov, Serhiy, Serebryakov, Dmitry, Bell Hechavarria, Ailec, Sevcenco, Adrian, Shabanov, Arseniy, Shabetai, Alexandre, Shahoyan, Ruben, Shaikh, Wadut, Shangaraev, Artem, Sharma, Anjali, Sharma, Ankita, Sharma, Himanshu, Sharma, Meenakshi, Bellini, Francesca, Sharma, Natasha, Sharma, Sheetal, Sheibani, Oveis, Shigaki, Kenta, Hachiya Shimomura, Maya, Shirinkin, Sergey, Shou, Qiye, Sibiryak, Yury, Siddhanta, Sabyasachi, Siemiarczuk, Teodor, Bellwied, Rene, Silvermyr, David Olle Rickard, Simatovic, Goran, Simonetti, Giuseppe, Singh, Bhawani, Singh, Ranbir, Singh, Randhir, Singh, Ravindra, Singh, Vivek, Singhal, Vikas, Sarkar - Sinha, Tinku, Belyaev, Vladimir, Sitar, Branislav, Sitta, Mario, Skaali, Bernhard, Slupecki, Maciej, Smirnov, Nikolai, Snellings, Raimond, Soncco Meza, Carlos, Song, Jihye, Songmoolnak, Arnon, Soramel, Francesca, Bencedi, Gyula, Sorensen, Soren Pontoppidan, Sputowska, Iwona Anna, Stachel, Johanna, Stan, Ionel, Steffanic, Patrick John, Stenlund, Evert Anders, Stiefelmaier, Stephan Friedrich, Stocco, Diego, Storetvedt, Maksim Melnik, Dello Stritto, Luigi, Beole, Stefania, Alarcon Do Passo Suaide, Alexandre, Sugitate, Toru, Suire, Christophe Pierre, Suleymanov, Mais Kazim Oglu, Suljic, Miljenko, Sultanov, Rishat, Sumbera, Michal, Sumberia, Vikash, Sumowidagdo, Suharyo, Swain, Sagarika, Bercuci, Alexandru, Szabo, Alexander, Szarka, Imrich, Tabassam, Uzma, Taghavi, Seyed Farid, Taillepied, Guillaume, Takahashi, Jun, Tambave, Ganesh Jagannath, Tang, Siyu, Tarhini, Mohamad, Tarzila, Madalina-gabriela, Ahmad, Shakeel, Berdnikov, Yaroslav, Tauro, Arturo, Tejeda Munoz, Guillermo, Telesca, Adriana, Terlizzi, Livia, Terrevoli, Cristina, Thakur, Dhananjaya, Thakur, Sanchari, Thomas, Deepa, Thoresen, Freja, Tieulent, Raphael Noel, Berenyi, Daniel, Tikhonov, Anatoly, Timmins, Anthony Robert, Toia, Alberica, Topilskaya, Nataliya, Toppi, Marco, Torales Acosta, Fernando, Rojas Torres, Solangel, Trifiro, Antonio, Tripathy, Sushanta, Tripathy, Tulika, Bertens, Redmer Alexander, Trogolo, Stefano, Trombetta, Giuseppe, Tropp, Lukas, Trubnikov, Victor, Trzaska, Wladyslaw Henryk, Trzcinski, Tomasz Piotr, Trzeciak, Barbara Antonina, Tumkin, Alexandr, Turrisi, Rosario, Tveter, Trine Spedstad, Berzano, Dario, Ullaland, Kjetil, Umaka, Ejiro Naomi, Uras, Antonio, Usai, Gianluca, Vala, Martin, Valle, Nicolo', Vallero, Sara, Van Der Kolk, Naomi, Van Doremalen, Lennart, Van Leeuwen, Marco, Besoiu, Mihaela Gabriela, Vande Vyvre, Pierre, Varga, Dezso, Varga, Zoltan, Varga-kofarago, Monika, Diozcora Vargas Trevino, Aurora, Vasileiou, Maria, Vasiliev, Andrey, Vazquez Doce, Oton, Vechernin, Vladimir, Vercellin, Ermanno, Betev, Latchezar, Vergara Limon, Sergio, Vermunt, Lucas Anne, Vernet, Renaud, Vertesi, Robert, Vickovic, Linda, Vilakazi, Zabulon, Villalobos Baillie, Orlando, Vino, Gioacchino, Vinogradov, Alexander, Virgili, Tiziano, Bhasin, Anju, Vislavicius, Vytautas, Vodopyanov, Alexander, Volkel, Benedikt, Volkl, Martin Andreas, Voloshin, Kirill, Voloshin, Sergey, Volpe, Giacomo, Von Haller, Barthelemy, Vorobyev, Ivan, Voscek, Dominik, Bhat, Inayat Rasool, Vrlakova, Janka, Wagner, Boris, Weber, Michael, Weber, Steffen Georg, Wegrzynek, Adam Tadeusz, Wenzel, Sandro Christian, Wessels, Johannes Peter, Wiechula, Jens, Wikne, Jon, Wilk, Grzegorz Andrzej, Bhat, Mohammad Asif, Wilkinson, Jeremy John, Willems, Guido Alexander, Willsher, Emily Jade, Windelband, Bernd Stefan, Winn, Michael Andreas, Witt, William Edward, Wright, Josephina Rae, Wu, Yitao, Xu, Ran, Yalcin Kuzu, Serpil, Bhatt, Himani, Yamaguchi, Yorito, Yamakawa, Kosei, Yang, Shiming, Yano, Satoshi, Yin, Zhongbao, Yokoyama, Hiroki, Yoo, In Kwon, Yoon, Jin Hee, Yuan, Shiming, Yuncu, Alperen, Acharya, S., Adamova, D., Adler, A., Adolfsson, J., Aggarwal, M. M., Rinella, G. A., Agnello, M., Agrawal, N., Ahammed, Z., Ahmad, S., Ahn, S. U., Akbar, Z., Akindinov, A., Al-Turany, M., Alam, S. N., Albuquerque, D. S. D., Aleksandrov, D., Alessandro, B., Alfanda, H. M., Molina, R. A., Ali, B., Ali, Y., Alici, A., Alizadehvandchali, N., Alkin, A., Alme, J., Alt, T., Altenkamper, L., Altsybeev, I., Anaam, M. N., Andrei, C., Andreou, D., Andronic, A., Angeletti, M., Anguelov, V., Anson, C., Anticic, T., Antinori, F., Antonioli, P., Apadula, N., Aphecetche, L., Appelshauser, H., Arcelli, S., Arnaldi, R., Arratia, M., Arsene, I. C., Arslandok, M., Augustinus, A., Averbeck, R., Aziz, S., Azmi, M. D., Badala, A., Baek, Y. W., Bagnasco, S., Bai, X., Bailhache, R., Bala, R., Balbino, A., Baldisseri, A., Ball, M., Balouza, S., Banerjee, D., Barbera, R., Barioglio, L., Barnafoldi, G. G., Barnby, L. S., Barret, V., Bartalini, P., Bartels, C., Barth, K., Bartsch, E., Baruffaldi, F., Bastid, N., Basu, S., Batigne, G., Batyunya, B., Bauri, D., Alba, J. L. B., Bearden, I. G., Beattie, C., Bedda, C., Behera, N. K., Belikov, I., Hechavarria, A. D. C. B., Bellini, F., Bellwied, R., Belyaev, V., Bencedi, G., Beole, S., Bercuci, A., Berdnikov, Y., Berenyi, D., Bertens, R. A., Berzano, D., Besoiu, M. G., Betev, L., Bhasin, A., Bhat, I. R., Bhat, M. A., Bhatt, H., Bhattacharjee, B., Bianchi, A., Bianchi, L., Bianchi, N., Bielcik, J., Bielcikova, J., Bilandzic, A., Biro, G., Biswas, R., Biswas, S., Blair, J. T., Blau, D., Blume, C., Boca, G., Bock, F., Bogdanov, A., Boi, S., Bok, J., Boldizsar, L., Bolozdynya, A., Bombara, M., Bonomi, G., Borel, H., Borissov, A., Bossi, H., Botta, E., Bratrud, L., Braun-Munzinger, P., Bregant, M., Broz, M., Bruna, E., Bruno, G. E., Buckland, M. D., Budnikov, D., Buesching, H., Bufalino, S., Bugnon, O., Buhler, P., Buncic, P., Buthelezi, Z., Butt, J. B., Bysiak, S. A., Caffarri, D., Caliva, A., Villar, E. C., Camacho, J. M. M., Camacho, R. S., Camerini, P., Canedo, F. D. M., Capon, A. A., Carnesecchi, F., Caron, R., Castellanos, J. C., Castro, A. J., Casula, E. A. R., Catalano, F., Sanchez, C. C., Chakraborty, P., Chandra, S., Chang, W., Chapeland, S., Chartier, M., Chattopadhyay, S., Chauvin, A., Cheshkov, C., Cheynis, B., Barroso, V. C., Chinellato, D. D., Cho, S., Chochula, P., Chowdhury, T., Christakoglou, P., Christensen, C. H., Christiansen, P., Chujo, T., Cicalo, C., Cifarelli, L., Cilladi, L. D., Cindolo, F., Ciupek, M. R., Clai, G., Cleymans, J., Colamaria, F., Colella, D., Collu, A., Colocci, M., Concas, M., Balbastre, G. C., del Valle, Z. C., Contin, G., Contreras, J. G., Cormier, T. M., Morales, Y. C., Cortese, P., Cosentino, M. R., Costa, F., Costanza, S., Crochet, P., Cuautle, E., Cui, P., Cunqueiro, L., Dabrowski, D., Dahms, T., Dainese, A., Damas, F. P. A., Danisch, M. C., Danu, A., Das, D., Das, I., Das, P., Das, S., Dash, A., Dash, S., De, S., De Caro, A., de Cataldo, G., de Cuveland, J., De Falco, A., De Gruttola, D., De Marco, N., De Pasquale, S., Deb, S., Degenhardt, H. F., Deja, K. R., Deloff, A., Delsanto, S., Deng, W., Dhankher, P., Di Bari, D., Di Mauro, A., Diaz, R. A., Dietel, T., Dillenseger, P., Ding, Y., Divia, R., Dixit, D. U., Djuvsland, O., Dmitrieva, U., Dobrin, A., Donigus, B., Dordic, O., Dubey, A. K., Dubla, A., Dudi, S., Dukhishyam, M., Dupieux, P., Ehlers, R. J., Eikeland, V. N., Elia, D., Erazmus, B., Erhardt, F., Erokhin, A., Ersdal, M. R., Espagnon, B., Eulisse, G., Evans, D., Evdokimov, S., Fabbietti, L., Faggin, M., Faivre, J., Fan, F., Fantoni, A., Fasel, M., Fecchio, P., Feliciello, A., Feofilov, G., Tellez, A. F., Ferrero, A., Ferretti, A., Festanti, A., Feuillard, V. J. G., Figiel, J., Filchagin, S., Finogeev, D., Fionda, F. M., Fiorenza, G., Flor, F., Flores, A. N., Foertsch, S., Foka, P., Fokin, S., Fragiacomo, E., Frankenfeld, U., Fuchs, U., Furget, C., Furs, A., Girard, M. F., Gaardhoje, J. J., Gagliardi, M., Gago, A. M., Gal, A., Galvan, C. D., Ganoti, P., Garabatos, C., Garcia, J. R. A., Garcia-Solis, E., Garg, K., Gargiulo, C., Garibli, A., Garner, K., Gasik, P., Gauger, E. F., Ducati, M. B. G., Germain, M., Ghosh, J., Ghosh, P., Ghosh, S. K., Giacalone, M., Gianotti, P., Giubellino, P., Giubilato, P., Glaenzer, A. M. C., Glassel, P., Ramirez, A. G., Gonzalez, V., Gonzalez-Trueba, L. H., Gorbunov, S., Gorlich, L., Goswami, A., Gotovac, S., Grabski, V., Graczykowski, L. K., Graham, K. L., Greiner, L., Grelli, A., Grigoras, C., Grigoriev, V., Grigoryan, A., Grigoryan, S., Groettvik, O. S., Grosa, F., Grosse-Oetringhaus, J. F., Grosso, R., Guernane, R., Guittiere, M., Gulbrandsen, K., Gunji, T., Gupta, A., Gupta, R., Guzman, I. B., Haake, R., Habib, M. K., Hadjidakis, C., Hamagaki, H., Hamar, G., Hamid, M., Hannigan, R., Haque, M. R., Harlenderova, A., Harris, J. W., Harton, A., Hasenbichler, J. A., Hassan, H., Hassan, Q. U., Hatzifotiadou, D., Hauer, P., Havener, L. B., Hayashi, S., Heckel, S. T., Hellbar, E., Helstrup, H., Herghelegiu, A., Herman, T., Hernandez, E. G., Corral, G. H., Herrmann, F., Hetland, K. F., Hillemanns, H., Hills, C., Hippolyte, B., Hohlweger, B., Honermann, J., Horak, D., Hornung, A., Hornung, S., Hosokawa, R., Hristov, P., Huang, C., Hughes, C., Huhn, P., Humanic, T. J., Hushnud, H., Husova, L. A., Hussain, N., Hussain, S. A., Hutter, D., Iddon, J. P., Ilkaev, R., Ilyas, H., Inaba, M., Innocenti, G. M., Ippolitov, M., Isakov, A., Islam, M. S., Ivanov, M., Ivanov, V., Izucheev, V., Jacak, B., Jacazio, N., Jacobs, P. M., Jadlovska, S., Jadlovsky, J., Jaelani, S., Jahnke, C., Jakubowska, M. J., Janik, M. A., Janson, T., Jercic, M., Jevons, O., Jin, M., Jonas, F., Jones, P. G., Jung, J., Jung, M., Jusko, A., Kalinak, P., Kalweit, A., Kaplin, V., Kar, S., Uysal, A. K., Karatovic, D., Karavichev, O., Karavicheva, T., Karczmarczyk, P., Karpechev, E., Kazantsev, A., Kebschull, U., Keidel, R., Keil, M., Ketzer, B., Khabanova, Z., Khan, A. M., Khan, S., Khanzadeev, A., Kharlov, Y., Khatun, A., Khuntia, A., Kileng, B., Kim, B., Kim, D., Kim, D. J., Kim, E. J., Kim, H., Kim, J., Kim, J. S., Kim, M., Kim, S., Kim, T., Kirsch, S., Kisel, I., Kiselev, S., Kisiel, A., Klay, J. L., Klein, C., Klein, J., Klein, S., Klein-Bosing, C., Kleiner, M., Kluge, A., Knichel, M. L., Knospe, A. G., Kobdaj, C., Kohler, M. K., Kollegger, T., Kondratyev, A., Kondratyeva, N., Kondratyuk, E., Konig, J., Konigstorfer, S. A., Konopka, P. J., Kornakov, G., Koska, L., Kovalenko, O., Kovalenko, V., Kowalski, M., Kralik, I., Kravcakova, A., Kreis, L., Krivda, M., Krizek, F., Gajdosova, K. K., Kruger, M., Kryshen, E., Krzewicki, M., Kubera, A. M., Kucera, V., Kuhn, C., Kuijer, P. G., Kumar, L., Kundu, S., Kurashvili, P., Kurepin, A., Kurepin, A. B., Kuryakin, A., Kushpil, S., Kvapil, J., Kweon, M. J., Kwon, J. Y., Kwon, Y., La Pointe, S. L., La Rocca, P., Lai, Y. S., Lamanna, M., Langoy, R., Lapidus, K., Lardeux, A., Larionov, P., Laudi, E., Lavicka, R., Lazareva, T., Lea, R., Leardini, L., Lee, J., Lee, S., Lehner, S., Lehrbach, J., Lemmon, R. C., Monzon, I. L., Lesser, E. D., Lettrich, M., Levai, P., Li, X., Li, X. L., Lien, J., Lietava, R., Lim, B., Lindenstruth, V., Lindner, A., Lippmann, C., Lisa, M. A., Liu, A., Liu, J., Liu, S., Llope, W. J., Lofnes, I. M., Loginov, V., Loizides, C., Loncar, P., Lopez, J. A., Lopez, X., Torres, E. L., Luhder, J. R., Lunardon, M., Luparello, G., Ma, Y. G., Maevskaya, A., Mager, M., Mahmood, S. M., Mahmoud, T., Maire, A., Majka, R. D., Malaev, M., Malik, Q. W., Malinina, L., Mal'Kevich, D., Malzacher, P., Mandaglio, G., Manko, V., Manso, F., Manzari, V., Mao, Y., Marchisone, M., Mares, J., Margagliotti, G. V., Margotti, A., Marin, A., Markert, C., Marquard, M., Martin, C. D., Martin, N. A., Martinengo, P., Martinez, J. L., Martinez, M. I., Garcia, G. M., Masciocchi, S., Masera, M., Masoni, A., Massacrier, L., Masson, E., Mastroserio, A., Mathis, A. M., Matonoha, O., Matuoka, P. F. T., Matyja, A., Mayer, C., Mazzaschi, F., Mazzilli, M., Mazzoni, M. A., Mechler, A. F., Meddi, F., Melikyan, Y., Menchaca-Rocha, A., Mengke, C., Meninno, E., Menon, A. S., Meres, M., Mhlanga, S., Miake, Y., Micheletti, L., Migliorin, L. C., Mihaylov, D. L., Mikhaylov, K., Mishra, A. N., Miskowiec, D., Modak, A., Mohammadi, N., Mohanty, A. P., Mohanty, B., Khan, M. M., Moravcova, Z., Mordasini, C., Moreira De Godoy, D. A., Moreno, L. A. P., Morozov, I., Morsch, A., Mrnjavac, T., Muccifora, V., Mudnic, E., Muhlheim, D., Muhuri, S., Mulligan, J. D., Mulliri, A., Munhoz, M. G., Munzer, R. H., Murakami, H., Murray, S., Musa, L., Musinsky, J., Myers, C. J., Myrcha, J. W., Naik, B., Nair, R., Nandi, B. K., Nania, R., Nappi, E., Naru, M. U., Nassirpour, A. F., Nattrass, C., Nayak, R., Nayak, T. K., Nazarenko, S., Neagu, A., Negrao De Oliveira, R. A., Nellen, L., Nesbo, S. V., Neskovic, G., Nesterov, D., Neumann, L. T., Nielsen, B. S., Nikolaev, S., Nikulin, S., Nikulin, V., Noferini, F., Nomokonov, P., Norman, J., Novitzky, N., Nowakowski, P., Nyanin, A., Nystrand, J., Ogino, M., Ohlson, A., Oleniacz, J., Da Silva, A. C. O., Oliver, M. H., Oppedisano, C., Velasquez, A. O., Oskarsson, A., Otwinowski, J., Oyama, K., Pachmayer, Y., Pacik, V., Padhan, S., Pagano, D., Paic, G., Pan, J., Panebianco, S., Pareek, P., Park, J., Parkkila, J. E., Parmar, S., Pathak, S. P., Paul, B., Pazzini, J., Pei, H., Peitzmann, T., Peng, X., Pereira, L. G., Da Costa, H. P., Peresunko, D., Perez, G. M., Perrin, S., Pestov, Y., Petracek, V., Petrovici, M., Pezzi, R. P., Piano, S., Pikna, M., Pillot, P., Pinazza, O., Pinsky, L., Pinto, C., Pisano, S., Pistone, D., Ploskon, M., Planinic, M., Pliquett, F., Poghosyan, M. G., Polichtchouk, B., Poljak, N., Pop, A., Porteboeuf-Houssais, S., Pozdniakov, V., Prasad, S. K., Preghenella, R., Prino, F., Pruneau, C. A., Pshenichnov, I., Puccio, M., Putschke, J., Qiu, S., Quaglia, L., Quishpe, R. E., Ragoni, S., Raha, S., Rajput, S., Rak, J., Rakotozafindrabe, A., Ramello, L., Rami, F., Ramirez, S. A. R., Raniwala, R., Raniwala, S., Rasanen, S. S., Rath, R., Ratza, V., Ravasenga, I., Read, K. F., Redelbach, A. R., Redlich, K., Rehman, A., Reichelt, P., Reidt, F., Ren, X., Renfordt, R., Rescakova, Z., Reygers, K., Riabov, A., Riabov, V., Richert, T., Richter, M., Riedler, P., Riegler, W., Riggi, F., Ristea, C., Rode, S. P., Cahuantzi, M. R., Roed, K., Rogalev, R., Rogochaya, E., Rohr, D., Rohrich, D., Rojas, P. F., Rokita, P. S., Ronchetti, F., Rosano, A., Rosas, E. D., Roslon, K., Rossi, A., Rotondi, A., Roy, A., Roy, P., Rueda, O. V., Rui, R., Rumyantsev, B., Rustamov, A., Ryabinkin, E., Ryabov, Y., Rybicki, A., Rytkonen, H., Saarimaki, O. A. M., Sadek, R., Sadhu, S., Sadovsky, S., Safarik, K., Saha, S. K., Sahoo, B., Sahoo, P., Sahoo, R., Sahoo, S., Sahu, P. K., Saini, J., Sakai, S., Sambyal, S., Samsonov, V., Sarkar, D., Sarkar, N., Sarma, P., Sarti, V. M., Sas, M. H. P., Scapparone, E., Schambach, J., Scheid, H. S., Schiaua, C., Schicker, R., Schmah, A., Schmidt, C., Schmidt, H. R., Schmidt, M. O., Schmidt, M., Schmidt, N. V., Schmier, A. R., Schukraft, J., Schutz, Y., Schwarz, K., Schweda, K., Scioli, G., Scomparin, E., Seger, J. E., Sekiguchi, Y., Sekihata, D., Selyuzhenkov, I., Senyukov, S., Serebryakov, D., Sevcenco, A., Shabanov, A., Shabetai, A., Shahoyan, R., Shaikh, W., Shangaraev, A., Sharma, A., Sharma, H., Sharma, M., Sharma, N., Sharma, S., Sheibani, O., Shigaki, K., Shimomura, M., Shirinkin, S., Shou, Q., Sibiriak, Y., Siddhanta, S., Siemiarczuk, T., Silvermyr, D., Simatovic, G., Simonetti, G., Singh, B., Singh, R., Singh, V. K., Singhal, V., Sinha, T., Sitar, B., Sitta, M., Skaali, T. B., Slupecki, M., Smirnov, N., Snellings, R. J. M., Soncco, C., Song, J., Songmoolnak, A., Soramel, F., Sorensen, S., Sputowska, I., Stachel, J., Stan, I., Steffanic, P. J., Stenlund, E., Stiefelmaier, S. F., Stocco, D., Storetvedt, M. M., Stritto, L. D., Suaide, A. A. P., Sugitate, T., Suire, C., Suleymanov, M., Suljic, M., Sultanov, R., Sumbera, M., Sumberia, V., Sumowidagdo, S., Swain, S., Szabo, A., Szarka, I., Tabassam, U., Taghavi, S. F., Taillepied, G., Takahashi, J., Tambave, G. J., Tang, S., Tarhini, M., Tarzila, M. G., Tauro, A., Munoz, G. T., Telesca, A., Terlizzi, L., Terrevoli, C., Thakur, D., Thakur, S., Thomas, D., Thoresen, F., Tieulent, R., Tikhonov, A., Timmins, A. R., Toia, A., Topilskaya, N., Toppi, M., Torales-Acosta, F., Torres, S. R., Trifiro, A., Tripathy, S., Tripathy, T., Trogolo, S., Trombetta, G., Tropp, L., Trubnikov, V., Trzaska, W. H., Trzcinski, T. P., Trzeciak, B. A., Tumkin, A., Turrisi, R., Tveter, T. S., Ullaland, K., Umaka, E. N., Uras, A., Usai, G. L., Vala, M., Valle, N., Vallero, S., van der Kolk, N., van Doremalen, L. V. R., van Leeuwen, M., Vyvre, P. V., Varga, D., Varga, Z., Varga-Kofarago, M., Vargas, A., Vasileiou, M., Vasiliev, A., Doce, O. V., Vechernin, V., Vercellin, E., Limon, S. V., Vermunt, L., Vernet, R., Vertesi, R., Vickovic, L., Vilakazi, Z., Baillie, O. V., Vino, G., Vinogradov, A., Virgili, T., Vislavicius, V., Vodopyanov, A., Volkel, B., Volkl, M. A., Voloshin, K., Voloshin, S. A., Volpe, G., von Haller, B., Vorobyev, I., Voscek, D., Vrlakova, J., Wagner, B., Weber, M., Weber, S. G., Wegrzynek, A., Wenzel, S. C., Wessels, J. P., Wiechula, J., Wikne, J., Wilk, G., Wilkinson, J., Willems, G. A., Willsher, E., Windelband, B., Winn, M., Witt, W. E., Wright, J. R., Wu, Y., Xu, R., Yalcin, S., Yamaguchi, Y., Yamakawa, K., Yang, S., Yano, S., Yin, Z., Yokoyama, H., Yoo, I. -K., Yoon, J. H., Yuan, S., Yuncu, A., Yurchenko, V., Zaccolo, V., Zaman, A., Zampolli, C., Zanoli, H. J. C., Zardoshti, N., Zarochentsev, A., Zavada, P., Zaviyalov, N., Zbroszczyk, H., Zhalov, M., Zhang, S., Zhang, X., Zhang, Z., Zherebchevskii, V., Zhi, Y., Zhou, D., Zhou, Y., Zhou, Z., Zhu, J., Zhu, Y., Zichichi, A., Zinovjev, G., Zurlo, N., Laboratoire de physique subatomique et des technologies associées (SUBATECH), Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-IMT Atlantique Bretagne-Pays de la Loire (IMT Atlantique), Institut Mines-Télécom [Paris] (IMT)-Institut Mines-Télécom [Paris] (IMT), Laboratoire de Physique des 2 Infinis Irène Joliot-Curie (IJCLab), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Département de Physique Nucléaire (ex SPhN) (DPHN), Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Laboratoire de Physique de Clermont (LPC), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Institut Pluridisciplinaire Hubert Curien (IPHC), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Institut de Physique Nucléaire de Lyon (IPNL), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Laboratoire de Physique Subatomique et de Cosmologie (LPSC), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP ), Université Grenoble Alpes (UGA), Centre de Calcul de l'IN2P3 (CC-IN2P3), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), ALICE, Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-IMT Atlantique (IMT Atlantique), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS), Université de Strasbourg (UNISTRA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS), S. Acharya, D. Adamová, A. Adler, J. Adolfsson, M. M. Aggarwal, G. Aglieri Rinella, M. Agnello, N. Agrawal, Z. Ahammed, S. Ahmad, S. U. Ahn, Z. Akbar, A. Akindinov, M. Al-Turany, S. N. Alam, D. S. D. Albuquerque, D. Aleksandrov, B. Alessandro, H. M. Alfanda, R. Alfaro Molina, B. Ali, Y. Ali, A. Alici, N. Alizadehvandchali, A. Alkin, J. Alme, T. Alt, L. Altenkamper, I. Altsybeev, M. N. Anaam, C. Andrei, D. Andreou, A. Andronic, M. Angeletti, V. Anguelov, C. Anson, T. Antičić, F. Antinori, P. Antonioli, N. Apadula, L. Aphecetche, H. Appelshäuser, S. Arcelli, R. Arnaldi, M. Arratia, I. C. Arsene, M. Arslandok, A. Augustinus, R. Averbeck, S. Aziz, M. D. Azmi, A. Badalà, Y. W. Baek, S. Bagnasco, X. Bai, R. Bailhache, R. Bala, A. Balbino, A. Baldisseri, M. Ball, S. Balouza, D. Banerjee, R. Barbera, L. Barioglio, G. G. Barnaföldi, L. S. Barnby, V. Barret, P. Bartalini, C. Bartels, K. Barth, E. Bartsch, F. Baruffaldi, N. Bastid, S. Basu, G. Batigne, B. Batyunya, D. Bauri, J. L. Bazo Alba, I. G. Bearden, C. Beattie, C. Bedda, N. K. Behera, I. Belikov, A. D. C. Bell Hechavarria, F. Bellini, R. Bellwied, V. Belyaev, G. Bencedi, S. Beole, A. Bercuci, Y. Berdnikov, D. Berenyi, R. A. Bertens, D. Berzano, M. G. Besoiu, L. Betev, A. Bhasin, I. R. Bhat, M. A. Bhat, H. Bhatt, B. Bhattacharjee, A. Bianchi, L. Bianchi, N. Bianchi, J. Bielčík, J. Bielčíková, A. Bilandzic, G. Biro, R. Biswas, S. Biswas, J. T. Blair, D. Blau, C. Blume, G. Boca, F. Bock, A. Bogdanov, S. Boi, J. Bok, L. Boldizsár, A. Bolozdynya, M. Bombara, G. Bonomi, H. Borel, A. Borissov, H. Bossi, E. Botta, L. Bratrud, P. Braun-Munzinger, M. Bregant, M. Broz, E. Bruna, G. E. Bruno, M. D. Buckland, D. Budnikov, H. Buesching, S. Bufalino, O. Bugnon, P. Buhler, P. Buncic, Z. Buthelezi, J. B. Butt, S. A. Bysiak, D. Caffarri, A. Caliva, E. Calvo Villar, J. M. M. Camacho, R. S. Camacho, P. Camerini, F. D. M. Canedo, A. A. Capon, F. Carnesecchi, R. Caron, J. Castillo Castellanos, A. J. Castro, E. A. R. Casula, F. Catalano, C. Ceballos Sanchez, P. Chakraborty, S. Chandra, W. Chang, S. Chapeland, M. Chartier, S. Chattopadhyay, S. Chattopadhyay, A. Chauvin, C. Cheshkov, B. Cheynis, V. Chibante Barroso, D. D. Chinellato, S. Cho, P. Chochula, T. Chowdhury, P. Christakoglou, C. H. Christensen, P. Christiansen, T. Chujo, C. Cicalo, L. Cifarelli, L. D. Cilladi, F. Cindolo, M. R. Ciupek, G. Clai, J. Cleymans, F. Colamaria, D. Colella, A. Collu, M. Colocci, M. Concas, G. Conesa Balbastre, Z. Conesa del Valle, G. Contin, J. G. Contreras, T. M. Cormier, Y. Corrales Morales, P. Cortese, M. R. Cosentino, F. Costa, S. Costanza, P. Crochet, E. Cuautle, P. Cui, L. Cunqueiro, D. Dabrowski, T. Dahms, A. Dainese, F. P. A. Damas, M. C. Danisch, A. Danu, D. Das, I. Das, P. Das, P. Das, S. Das, A. Dash, S. Dash, S. De, A. De Caro, G. de Cataldo, J. de Cuveland, A. De Falco, D. De Gruttola, N. De Marco, S. De Pasquale, S. Deb, H. F. Degenhardt, K. R. Deja, A. Deloff, S. Delsanto, W. Deng, P. Dhankher, D. Di Bari, A. Di Mauro, R. A. Diaz, T. Dietel, P. Dillenseger, Y. Ding, R. Divià, D. U. Dixit, Ø. Djuvsland, U. Dmitrieva, A. Dobrin, B. Dönigus, O. Dordic, A. K. Dubey, A. Dubla, S. Dudi, M. Dukhishyam, P. Dupieux, R. J. Ehlers, V. N. Eikeland, D. Elia, B. Erazmus, F. Erhardt, A. Erokhin, M. R. Ersdal, B. Espagnon, G. Eulisse, D. Evans, S. Evdokimov, L. Fabbietti, M. Faggin, J. Faivre, F. Fan, A. Fantoni, M. Fasel, P. Fecchio, A. Feliciello, G. Feofilov, A. Fernández Téllez, A. Ferrero, A. Ferretti, A. Festanti, V. J. G. Feuillard, J. Figiel, S. Filchagin, D. Finogeev, F. M. Fionda, G. Fiorenza, F. Flor, A. N. Flores, S. Foertsch, P. Foka, S. Fokin, E. Fragiacomo, U. Frankenfeld, U. Fuchs, C. Furget, A. Furs, M. Fusco Girard, J. J. Gaardhøje, M. Gagliardi, A. M. Gago, A. Gal, C. D. Galvan, P. Ganoti, C. Garabatos, J. R. A. Garcia, E. Garcia-Solis, K. Garg, C. Gargiulo, A. Garibli, K. Garner, P. Gasik, E. F. Gauger, M. B. Gay Ducati, M. Germain, J. Ghosh, P. Ghosh, S. K. Ghosh, M. Giacalone, P. Gianotti, P. Giubellino, P. Giubilato, A. M. C. Glaenzer, P. Glässel, A. Gomez Ramirez, V. Gonzalez, L. H. González-Trueba, S. Gorbunov, L. Görlich, A. Goswami, S. Gotovac, V. Grabski, L. K. Graczykowski, K. L. Graham, L. Greiner, A. Grelli, C. Grigoras, V. Grigoriev, A. Grigoryan, S. Grigoryan, O. S. Groettvik, F. Grosa, J. F. Grosse-Oetringhaus, R. Grosso, R. Guernane, M. Guittiere, K. Gulbrandsen, T. Gunji, A. Gupta, R. Gupta, I. B. Guzman, R. Haake, M. K. Habib, C. Hadjidakis, H. Hamagaki, G. Hamar, M. Hamid, R. Hannigan, M. R. Haque, A. Harlenderova, J. W. Harris, A. Harton, J. A. Hasenbichler, H. Hassan, Q. U. Hassan, D. Hatzifotiadou, P. Hauer, L. B. Havener, S. Hayashi, S. T. Heckel, E. Hellbär, H. Helstrup, A. Herghelegiu, T. Herman, E. G. Hernandez, G. Herrera Corral, F. Herrmann, K. F. Hetland, H. Hillemanns, C. Hills, B. Hippolyte, B. Hohlweger, J. Honermann, D. Horak, A. Hornung, S. Hornung, R. Hosokawa, P. Hristov, C. Huang, C. Hughes, P. Huhn, T. J. Humanic, H. Hushnud, L. A. Husova, N. Hussain, S. A. Hussain, D. Hutter, J. P. Iddon, R. Ilkaev, H. Ilyas, M. Inaba, G. M. Innocenti, M. Ippolitov, A. Isakov, M. S. Islam, M. Ivanov, V. Ivanov, V. Izucheev, B. Jacak, N. Jacazio, P. M. Jacobs, S. Jadlovska, J. Jadlovsky, S. Jaelani, C. Jahnke, M. J. Jakubowska, M. A. Janik, T. Janson, M. Jercic, O. Jevons, M. Jin, F. Jonas, P. G. Jones, J. Jung, M. Jung, A. Jusko, P. Kalinak, A. Kalweit, V. Kaplin, S. Kar, A. Karasu Uysal, D. Karatovic, O. Karavichev, T. Karavicheva, P. Karczmarczyk, E. Karpechev, A. Kazantsev, U. Kebschull, R. Keidel, M. Keil, B. Ketzer, Z. Khabanova, A. M. Khan, S. Khan, A. Khanzadeev, Y. Kharlov, A. Khatun, A. Khuntia, B. Kileng, B. Kim, B. Kim, D. Kim, D. J. Kim, E. J. Kim, H. Kim, J. Kim, J. S. Kim, J. Kim, J. Kim, J. Kim, M. Kim, S. Kim, T. Kim, T. Kim, S. Kirsch, I. Kisel, S. Kiselev, A. Kisiel, J. L. Klay, C. Klein, J. Klein, S. Klein, C. Klein-Bösing, M. Kleiner, A. Kluge, M. L. Knichel, A. G. Knospe, C. Kobdaj, M. K. Köhler, T. Kollegger, A. Kondratyev, N. Kondratyeva, E. Kondratyuk, J. Konig, S. A. Konigstorfer, P. J. Konopka, G. Kornakov, L. Koska, O. Kovalenko, V. Kovalenko, M. Kowalski, I. Králik, A. Kravčáková, L. Kreis, M. Krivda, F. Krizek, K. Krizkova Gajdosova, M. Krüger, E. Kryshen, M. Krzewicki, A. M. Kubera, V. Kučera, C. Kuhn, P. G. Kuijer, L. Kumar, S. Kundu, P. Kurashvili, A. Kurepin, A. B. Kurepin, A. Kuryakin, S. Kushpil, J. Kvapil, M. J. Kweon, J. Y. Kwon, Y. Kwon, S. L. La Pointe, P. La Rocca, Y. S. Lai, M. Lamanna, R. Langoy, K. Lapidus, A. Lardeux, P. Larionov, E. Laudi, R. Lavicka, T. Lazareva, R. Lea, L. Leardini, J. Lee, S. Lee, S. Lehner, J. Lehrbach, R. C. Lemmon, I. León Monzón, E. D. Lesser, M. Lettrich, P. Lévai, X. Li, X. L. Li, J. Lien, R. Lietava, B. Lim, V. Lindenstruth, A. Lindner, C. Lippmann, M. A. Lisa, A. Liu, J. Liu, S. Liu, W. J. Llope, I. M. Lofnes, V. Loginov, C. Loizides, P. Loncar, J. A. Lopez, X. Lopez, E. López Torres, J. R. Luhder, M. Lunardon, G. Luparello, Y. G. Ma, A. Maevskaya, M. Mager, S. M. Mahmood, T. Mahmoud, A. Maire, R. D. Majka, M. Malaev, Q. W. Malik, L. Malinina, D. Mal’Kevich, P. Malzacher, G. Mandaglio, V. Manko, F. Manso, V. Manzari, Y. Mao, M. Marchisone, J. Mareš, G. V. Margagliotti, A. Margotti, A. Marín, C. Markert, M. Marquard, C. D. Martin, N. A. Martin, P. Martinengo, J. L. Martinez, M. I. Martínez, G. Martínez García, S. Masciocchi, M. Masera, A. Masoni, L. Massacrier, E. Masson, A. Mastroserio, A. M. Mathis, O. Matonoha, P. F. T. Matuoka, A. Matyja, C. Mayer, F. Mazzaschi, M. Mazzilli, M. A. Mazzoni, A. F. Mechler, F. Meddi, Y. Melikyan, A. Menchaca-Rocha, C. Mengke, E. Meninno, A. S. Menon, M. Meres, S. Mhlanga, Y. Miake, L. Micheletti, L. C. Migliorin, D. L. Mihaylov, K. Mikhaylov, A. N. Mishra, D. Miśkowiec, A. Modak, N. Mohammadi, A. P. Mohanty, B. Mohanty, M. Mohisin Khan, Z. Moravcova, C. Mordasini, D. A. Moreira De Godoy, L. A. P. Moreno, I. Morozov, A. Morsch, T. Mrnjavac, V. Muccifora, E. Mudnic, D. Mühlheim, S. Muhuri, J. D. Mulligan, A. Mulliri, M. G. Munhoz, R. H. Munzer, H. Murakami, S. Murray, L. Musa, J. Musinsky, C. J. Myers, J. W. Myrcha, B. Naik, R. Nair, B. K. Nandi, R. Nania, E. Nappi, M. U. Naru, A. F. Nassirpour, C. Nattrass, R. Nayak, T. K. Nayak, S. Nazarenko, A. Neagu, R. A. Negrao De Oliveira, L. Nellen, S. V. Nesbo, G. Neskovic, D. Nesterov, L. T. Neumann, B. S. Nielsen, S. Nikolaev, S. Nikulin, V. Nikulin, F. Noferini, P. Nomokonov, J. Norman, N. Novitzky, P. Nowakowski, A. Nyanin, J. Nystrand, M. Ogino, A. Ohlson, J. Oleniacz, A. C. Oliveira Da Silva, M. H. Oliver, C. Oppedisano, A. Ortiz Velasquez, A. Oskarsson, J. Otwinowski, K. Oyama, Y. Pachmayer, V. Pacik, S. Padhan, D. Pagano, G. Paić, J. Pan, S. Panebianco, P. Pareek, J. Park, J. E. Parkkila, S. Parmar, S. P. Pathak, B. Paul, J. Pazzini, H. Pei, T. Peitzmann, X. Peng, L. G. Pereira, H. Pereira Da Costa, D. Peresunko, G. M. Perez, S. Perrin, Y. Pestov, V. Petráček, M. Petrovici, R. P. Pezzi, S. Piano, M. Pikna, P. Pillot, O. Pinazza, L. Pinsky, C. Pinto, S. Pisano, D. Pistone, M. Płoskoń, M. Planinic, F. Pliquett, M. G. Poghosyan, B. Polichtchouk, N. Poljak, A. Pop, S. Porteboeuf-Houssais, V. Pozdniakov, S. K. Prasad, R. Preghenella, F. Prino, C. A. Pruneau, I. Pshenichnov, M. Puccio, J. Putschke, S. Qiu, L. Quaglia, R. E. Quishpe, S. Ragoni, S. Raha, S. Rajput, J. Rak, A. Rakotozafindrabe, L. Ramello, F. Rami, S. A. R. Ramirez, R. Raniwala, S. Raniwala, S. S. Räsänen, R. Rath, V. Ratza, I. Ravasenga, K. F. Read, A. R. Redelbach, K. Redlich, A. Rehman, P. Reichelt, F. Reidt, X. Ren, R. Renfordt, Z. Rescakova, K. Reygers, A. Riabov, V. Riabov, T. Richert, M. Richter, P. Riedler, W. Riegler, F. Riggi, C. Ristea, S. P. Rode, M. Rodríguez Cahuantzi, K. Røed, R. Rogalev, E. Rogochaya, D. Rohr, D. Röhrich, P. F. Rojas, P. S. Rokita, F. Ronchetti, A. Rosano, E. D. Rosas, K. Roslon, A. Rossi, A. Rotondi, A. Roy, P. Roy, O. V. Rueda, R. Rui, B. Rumyantsev, A. Rustamov, E. Ryabinkin, Y. Ryabov, A. Rybicki, H. Rytkonen, O. A. M. Saarimaki, R. Sadek, S. Sadhu, S. Sadovsky, K. Šafařík, S. K. Saha, B. Sahoo, P. Sahoo, R. Sahoo, S. Sahoo, P. K. Sahu, J. Saini, S. Sakai, S. Sambyal, V. Samsonov, D. Sarkar, N. Sarkar, P. Sarma, V. M. Sarti, M. H. P. Sas, E. Scapparone, J. Schambach, H. S. Scheid, C. Schiaua, R. Schicker, A. Schmah, C. Schmidt, H. R. Schmidt, M. O. Schmidt, M. Schmidt, N. V. Schmidt, A. R. Schmier, J. Schukraft, Y. Schutz, K. Schwarz, K. Schweda, G. Scioli, E. Scomparin, J. E. Seger, Y. Sekiguchi, D. Sekihata, I. Selyuzhenkov, S. Senyukov, D. Serebryakov, A. Sevcenco, A. Shabanov, A. Shabetai, R. Shahoyan, W. Shaikh, A. Shangaraev, A. Sharma, A. Sharma, H. Sharma, M. Sharma, N. Sharma, S. Sharma, O. Sheibani, K. Shigaki, M. Shimomura, S. Shirinkin, Q. Shou, Y. Sibiriak, S. Siddhanta, T. Siemiarczuk, D. Silvermyr, G. Simatovic, G. Simonetti, B. Singh, R. Singh, R. Singh, R. Singh, V. K. Singh, V. Singhal, T. Sinha, B. Sitar, M. Sitta, T. B. Skaali, M. Slupecki, N. Smirnov, R. J. M. Snellings, C. Soncco, J. Song, A. Songmoolnak, F. Soramel, S. Sorensen, I. Sputowska, J. Stachel, I. Stan, P. J. Steffanic, E. Stenlund, S. F. Stiefelmaier, D. Stocco, M. M. Storetvedt, L. D. Stritto, A. A. P. Suaide, T. Sugitate, C. Suire, M. Suleymanov, M. Suljic, R. Sultanov, M. Šumbera, V. Sumberia, S. Sumowidagdo, S. Swain, A. Szabo, I. Szarka, U. Tabassam, S. F. Taghavi, G. Taillepied, J. Takahashi, G. J. Tambave, S. Tang, M. Tarhini, M. G. Tarzila, A. Tauro, G. Tejeda Muñoz, A. Telesca, L. Terlizzi, C. Terrevoli, D. Thakur, S. Thakur, D. Thomas, F. Thoresen, R. Tieulent, A. Tikhonov, A. R. Timmins, A. Toia, N. Topilskaya, M. Toppi, F. Torales-Acosta, S. R. Torres, A. Trifiró, S. Tripathy, T. Tripathy, S. Trogolo, G. Trombetta, L. Tropp, V. Trubnikov, W. H. Trzaska, T. P. Trzcinski, B. A. Trzeciak, A. Tumkin, R. Turrisi, T. S. Tveter, K. Ullaland, E. N. Umaka, A. Uras, G. L. Usai, M. Vala, N. Valle, S. Vallero, N. van der Kolk, L. V. R. van Doremalen, M. van Leeuwen, P. Vande Vyvre, D. Varga, Z. Varga, M. Varga-Kofarago, A. Vargas, M. Vasileiou, A. Vasiliev, O. Vázquez Doce, V. Vechernin, E. Vercellin, S. Vergara Limón, L. Vermunt, R. Vernet, R. Vértesi, L. Vickovic, Z. Vilakazi, O. Villalobos Baillie, G. Vino, A. Vinogradov, T. Virgili, V. Vislavicius, A. Vodopyanov, B. Volkel, M. A. Völkl, K. Voloshin, S. A. Voloshin, G. Volpe, B. von Haller, I. Vorobyev, D. Voscek, J. Vrláková, B. Wagner, M. Weber, S. G. Weber, A. Wegrzynek, S. C. Wenzel, J. P. Wessels, J. Wiechula, J. Wikne, G. Wilk, J. Wilkinson, G. A. Willems, E. Willsher, B. Windelband, M. Winn, W. E. Witt, J. R. Wright, Y. Wu, R. Xu, S. Yalcin, Y. Yamaguchi, K. Yamakawa, S. Yang, S. Yano, Z. Yin, H. Yokoyama, I.-K. Yoo, J. H. Yoon, S. Yuan, A. Yuncu, V. Yurchenko, V. Zaccolo, A. Zaman, C. Zampolli, H. J. C. Zanoli, N. Zardoshti, A. Zarochentsev, P. Závada, N. Zaviyalov, H. Zbroszczyk, M. Zhalov, S. Zhang, X. Zhang, Z. Zhang, V. Zherebchevskii, Y. Zhi, D. Zhou, Y. Zhou, Z. Zhou, J. Zhu, Y. Zhu, A. Zichichi, G. Zinovjev & N. Zurlo, Helsinki Institute of Physics, Sub Subatomic Physics (SAP), Afd Subatomic Physics (SAP), Sub Algemeen Physics Education, and Subatomic Physics

Subjects
EXCHANGE-POTENTIAL APPROACH, Strange quark, ALICE Collaboration, Hadron, Nuclear Theory, Strong interaction, hadron collisions, Position and momentum space, hiukkasfysiikka, nucl-ex, 7. Clean energy, 01 natural sciences, VDP::Fysikk: 430, High Energy Physics - Experiment, High Energy Physics - Experiment (hep-ex), Hadron-Hadron scattering (experiments), scattering [hadron], p p scattering, [PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex], scattering [p p], Nuclear Experiment (nucl-ex), Experimental nuclear physics, NUCLEON, Nuclear Experiment, VDP::Physics: 430, Physics, Multidisciplinary, Large Hadron Collider, strong interaction, lattice [space-time], Publisher Correction, PRIRODNE ZNANOSTI. Fizika, BARYON-BARYON SCATTERING, CERN LHC Coll, LHC, ddc:500, Nucleon, Particle Physics - Experiment, discrete [space-time], Quark, Particle physics, CERN Lab, General Science & Technology, FOS: Physical sciences, short-range, Hadron, strong interaction, LHC, 114 Physical sciences, Fysikk: 430 [VDP], Article, hadron scattering, quark, ultrarelativistic proton–proton collisions, LHC, ALICE, 0103 physical sciences, Nuclear Physics - Experiment, General, 010306 general physics, Physics: 430 [VDP], interaction [hadron hadron], hep-ex, 010308 nuclear & particles physics, High Energy Physics::Phenomenology, effect [strong interaction], hadron-hadron interaction, strong interaction: effect, space-time: discrete, space-time: lattice, correlation, NATURAL SCIENCES. Physics, Baryon, Hypernuclei, Neutron Stars, Strangeness, Physics::Accelerator Physics, High Energy Physics::Experiment, hadron, Experimental particle physics
Abstract

One of the key challenges for nuclear physics today is to understand from first principles the effective interaction between hadrons with different quark content. First successes have been achieved using techniques that solve the dynamics of quarks and gluons on discrete space-time lattices1,2. Experimentally, the dynamics of the strong interaction have been studied by scattering hadrons off each other. Such scattering experiments are difficult or impossible for unstable hadrons3–6 and so high-quality measurements exist only for hadrons containing up and down quarks7. Here we demonstrate that measuring correlations in the momentum space between hadron pairs8–12 produced in ultrarelativistic proton–proton collisions at the CERN Large Hadron Collider (LHC) provides a precise method with which to obtain the missing information on the interaction dynamics between any pair of unstable hadrons. Specifically, we discuss the case of the interaction of baryons containing strange quarks (hyperons). We demonstrate how, using precision measurements of proton–omega baryon correlations, the effect of the strong interaction for this hadron–hadron pair can be studied with precision similar to, and compared with, predictions from lattice calculations13,14. The large number of hyperons identified in proton–proton collisions at the LHC, together with accurate modelling15 of the small (approximately one femtometre) inter-particle distance and exact predictions for the correlation functions, enables a detailed determination of the short-range part of the nucleon-hyperon interaction., Correlations in momentum space between hadrons created by ultrarelativistic proton–proton collisions at the CERN Large Hadron Collider provide insights into the strong interaction, particularly the short-range dynamics of hyperons—baryons that contain strange quarks.

Published
2020
Full Text
View/download PDF

30. The Relationship between Serous Choroidal Detachment and the Ahmed Glaucoma Valve Failure.

Author

Yadgari M, Shojaei Baghini A, Vafaei F, Attarian B, Hatami M, Sheibani K, and Hooshmandi S

Abstract

Purpose: To investigate the effect of serous choroidal detachment (SCD) on the success of Ahmed glaucoma valve (AGV) implantation., Methods: Patients who underwent AGV implantation and developed SCD were included in the case group. The control group was matched based on age, sex, baseline intraocular pressure (IOP), glaucoma type, and the number of glaucoma medications. The patient data were retrospectively extracted from available records. The primary outcome measure was an AGV success rate based on 5 < IOP <18 and a 20% reduction from baseline., Results: Seventeen patients were enrolled in the case group and 38 in the control group. Preoperative visual acuity of patients was 1.17 ± 0.43 and 1.16 ± 0.37 logMAR in the case and control groups, respectively. The patients in the case group showed higher mean IOP at all time intervals compared to controls. However, the mean IOP only reached a statistically significant difference at 3 months (17.94 ± 6.78 mmHg vs. 13.39 ± 3.09 mmHg, P = 0.003). The mean survival duration was significantly shorter in patients with SCD (10.4 ± 0.7 months vs. 11.7 ± 0.2 months for controls log-rank = 4.1, P = 0.04). The cumulative probability of success was 76.5% in patients with SCD and 94.7% in the control group after 12 months., Conclusions: SCD after AGV implantation could be a risk factor for failure. A larger prospective study with a longer follow-up duration is required to confirm the present study results., Competing Interests: There are no conflicts of interest., (Copyright: © 2025 Journal of Current Ophthalmology.)

Published
2025
Full Text
View/download PDF

31. Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops.

Author

Mousavi SA, Rajavi Z, Sabbaghi H, Abdi S, Montazerin N, Kheiri B, Haseli-Mofrad A, Sheibani K, and Jaldian HB

Abstract

Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IR- Pilo) in comparison with its original brand-name drug (Vuity)., Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo ( n = 45) or Vuity ( n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop., Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups ( P < 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention., Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects., Competing Interests: None., (Copyright © 2024 Mousavi et al.)

Published
2024
Full Text
View/download PDF

32. Myopia Controlling using Low Dose Atropine Eye Drop.

Author

Rajavi Z, Kheiri B, Sheibani K, and Sabbaghi H

Abstract

Purpose: To determine myopic progression, axial length elongation, best-corrected visual acuity (BCVA), pupil dilation, and accommodation amplitude following 24 months of Atropine 0.01% usage among progressive myopic patients., Methods: Fifty-one progressive myopic patients (age range, 3.5-17 years) were included in the present study. Fifteen patients were excluded due to loss to follow-up (eight patients) and Atropine complications (seven patients) and 36 patients continued therapy. Myopic progression, axial length, far and near BCVA, pupil diameter, and accommodation amplitude were measured at baseline examination and repeated every 6 months up to 2 years. All patients were recommended to instill one drop of Atropine 0.01% in each eye every night. Absolute success of therapy was defined as myopic progression ≤0.50 diopter (D) and axial length growth ≤0.2 mm per year., Results: Mean myopic progression was 0.16 and 1.28 D and mean axial length change was 0.05 and 0.69 mm at months 12 and 24, respectively. Pupil dilation was 1.26 and 1.84 mm and accommodation reduction was 3.38 and 3.37 D at the same follow-ups, while BCVA was not changed. Absolute success rate for myopic progression control was 56.8% at 12 months and 70.8% at 24 months follow-up. In addition, the success rate in respect to axial length changes was 44.4% and 58.3% at the same time points., Conclusions: Atropine 0.01% can slow myopic progression and axial length elongation at least in 50% of myopic cases at 12- and 24-month follow-up with no significant complications. Therefore, Atropine therapy is recommended in cases of progressive myopia in children and teenagers., Competing Interests: There are no conflicts of interest., (Copyright: © 2024 Journal of Current Ophthalmology.)

Published
2024
Full Text
View/download PDF

33. Visual and Ocular Characteristics of Anisometropic Children.

Author

Rajavi Z, Behradfar N, Sharahi Dizabadi M, Kheiri B, Sheibani K, and Sabbaghi H

Abstract

Purpose: To compare the demographic and ocular characteristics of patients with low and high levels of anisometropia compared with non-anisometropic individuals., Methods: This cross-sectional study was conducted on 1803 individuals (age range, 1 to 30 years) examined at strabismus clinics between January 2019 and December 2020. Of these, 203 subjects had anisometropia (11.2%); 66 cases were excluded due to the history of prior ocular surgery except from strabismus surgery. Finally, data from 137 subjects were analyzed. Spherical or cylindrical differences of 1.50 or 3.00D between the two eyes were defined as low or high anisometropia, respectively, and isometropic subjects ( n = 1600) served as controls., Results: No significant difference was observed between cases and controls regarding age (10.25 ± 8.41 vs. 9.2 ± 1.7 years; P = 0.133) and sex ( P = 0.051). History of ocular surgery was present in 33% of anisometropic patients versus 0.8 % of isometropic cases. The rate of amblyopia was 83% and 2.3% in anisometropic and non-anisometropic groups, respectively. Best corrected visual acuity (BCVA) was comparable in amblyopic eyes in both study groups, while BCVA of non-amblyopic eyes of non-anisometropic subjects was better (non-anisometropic: 0.01 ± 0.01 vs. anisometropic: 0.06 ± 0.17 LogMAR; P = 0.001). Eye deviation was significantly more prevalent among anisometropic patients (36.5% vs. 3.25%, P < 0.001) and exotropia was the common type of deviation. Anisohyperopia and anisomyopia were the most common refractive errors under low and high anisometropia categories, respectively. Simultaneous manifestation of amblyopia and strabismus were observed in 30.6% of anisometropic cases, while only 0.7% of subjects with isometropia had a similar status ( P < 0.001)., Conclusion: High rates of amblyopia and strabismus in anisometropic subjects, especially with higher degrees of anomaly, indicate the necessity of early visual acuity and refractive error screening to improve detection and enhance the outcomes of treatment., Competing Interests: None., (Copyright © 2024 Rajavi et al.)

Published
2024
Full Text
View/download PDF

34. Vision-related quality of life in patients with retinal vein occlusion.

Author

Ramin S, Rostami F, Ahmadieh H, Daftarian N, Nourinia R, Abbasi A, Kheiri B, Sabbaghi H, and Sheibani K

Subjects
Humans, Middle Aged, Aged, Eye Pain, Surveys and Questionnaires, Quality of Life, Retinal Vein Occlusion diagnosis
Abstract

Purpose: This study aims to assess the vision-related quality of life in patients with retinal vein occlusion (RVO) among those referred to Labbafinejad Medical Center and Imam Hossein Hospital between 2019 and 2021., Methods: This comparative study included 37 eligible patients diagnosed with various types of RVO, with an average age of 61 ± 9. To ensure data validity, we included 74 age- and sex-matched healthy individuals. Only cases with a definitive diagnosis of RVO, confirmed by two retina specialists (ND and RN), were included. We assessed the vision-related quality of life of our participants using the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25). All participants underwent interviews., Results: In our study, we examined the vision-related quality of life in different subgroups of RVO patients. Overall, RVO patients had a significantly lower total VRQoL score compared to healthy individuals (P < 0.001), except in the subscale analysis of specific factors such as ocular pain, color vision, and driving, where no statistically significant difference was observed. A statistically significant difference was found in the comparison of subgroups, indicating lower VRQoL in central retinal vein occlusion (CRVO) patients (P = 0.010). Furthermore, a significant correlation was observed between lower VRQoL and decreased vision (P = 0.009) as well as longer disease duration (P = 0.011)., Conclusion: Retinal vein occlusion can significantly reduce vision-related quality of life, particularly in more severe cases., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)

Published
2024
Full Text
View/download PDF

35. Fundus torsion following inferior oblique muscle weakening.

Author

Rajavi Z, Nikanfar K, Sharahi Dizabadi M, Abdi S, Kheiri B, Sheibani K, and Sabbaghi H

Subjects
Female, Humans, Child, Adolescent, Male, Oculomotor Muscles surgery, Torsion Abnormality diagnosis, Torsion Abnormality surgery, Fundus Oculi, Ophthalmologic Surgical Procedures, Treatment Outcome, Retrospective Studies, Ocular Motility Disorders surgery, Eye Diseases surgery, Orbital Diseases surgery, Strabismus surgery
Abstract

Purpose: To determine the postoperative fundus torsion following surgical inferior oblique (IO) weakening in patients with inferior oblique overaction (IOOA)., Methods: In this interventional case series, 37 patients with IOOA ≥ +1 and reliable preoperative fundus photographs were included. IO weakening was accomplished through myectomy or anterior transposition. Fundus photography was repeated at 3 months' follow-up. The primary outcome was change of disk foveal angle (DFA), measured as the angle between the line connecting the center of the fovea and optic disk and horizontal. Success or normal fundus torsion was defined as a postoperative angle of 0° to 8° of extorsion. Residual extorsion was defined as postoperative extorsion of > 8°. Postoperative intorsion was defined as any amount of induced intorsion., Results: Mean age of patients (56% females) was 6.46 ± 6.79 years. At follow-up at least 3 months after surgery, the mean change of DFA was 7.79 ± 6.24° of reduction of extorsion after IO myectomy (P < 0.001) and 6.05 ± 6.07° after IO anterior transposition (P = 0.005). Normal fundus torsion was achieved in 50% of patients after myectomy and 36.4% of patients after anterior transposition. Residual extorsion was observed in 49% of patients; induced intorsion in 5%., Conclusions: Using objective measurement of fundus photographs, fundus extorsion was decreased in 94.7% of patients after myectomy or anterior transposition., (Copyright © 2024 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.)

Published
2024
Full Text
View/download PDF

36. Mutually exclusive driver mutations identifies 2 separate primaries in a collision tumor initially interpreted as a solitary lung adenocarcinoma with tumor heterogeneity.

Author

Torrez MM, Sheibani K, and Vasef MA

Abstract

Distinction of histologically heterogenous, single primary tumor from two or more collision tumors with different primaries could represent a challenge to practicing pathologists. Histologic variations including differences in degree of differentiating within a tumor, are typically interpreted as tumor heterogeneity in a contiguous small size tumor biopsy. The authors report a case of adult former smoker female who presented with lung mass and a metastatic lytic lesion of acetabulum. A needle biopsy of a lung mass revealed an adenocarcinoma with well and moderately differentiated components. Next generation sequencing studies proved 2 different primaries in this small needle biopsy., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)

Published
2024
Full Text
View/download PDF

37. The effect of topical ketorolac tromethamine on macular thickening after phacoemulsification in diabetic patients.

Author

Mohammad-Rabei H, Sabbaghi H, Emamverdi M, Karimi S, Ramezani A, Nikkhah H, Kheiri B, Yaseri M, Sheibani K, and Bahreini R

Subjects
Humans, Ketorolac Tromethamine therapeutic use, Ketorolac therapeutic use, Treatment Outcome, Visual Acuity, Tomography, Optical Coherence, Phacoemulsification, Macular Edema drug therapy, Macular Edema etiology, Macular Edema prevention & control, Diabetic Retinopathy complications, Diabetic Retinopathy drug therapy, Diabetes Mellitus
Abstract

Background: To determine the effect of ketorolac tromethamine 0.5% in preventing post-phacoemulsification macular thickening. This randomized clinical trial. patients randomized 1:1 to receive either topical ketorolac three times a day or a placebo., Methods: A total of 101 eyes of 101 diabetic patients who were scheduled for phacoemulsification and had normal macular contour and thickness enrolled consecutively. The topical ketorolac and placebo were prescribed on the day before surgery and continued up to 4 weeks after surgery. Patients with proliferative diabetic retinopathy, a history of intravitreal injection in less than three months, a history of macular photocoagulation in less than 6 months, and any other concomitant ocular pathologies were excluded. Central macular thickness (CMT) and best corrected visual acuity (BCVA) was recorded in the follow-ups of 6, 12, and 24 weeks after the surgery and compared with the controls., Results: 49 eyes in the case group and 52 eyes in the control group were analyzed. Mean BCVA was significantly improved in both groups at all follow-ups (P < 0.001 for all). There was no statistically significant difference regarding the BCVA in different time points except week 12 (P = 0.028) among the study group. In the case and control groups, CMT was increased at all follow-ups (P < 0.05). There was no statistically significant difference when comparing the two groups regarding the mean of CMT at any time point postoperatively (P > 0.05 for all)., Conclusion: Based on our findings, topical ketorolac tromethamine 0.5% is not effective in the prevention of post-phacoemulsification macular thickening in diabetic patients., Trail Registration: The study protocol was registered into www., Clinicaltrial: gov with the RCT registration number NCT03551808. (2018/06/11 ) CLINICAL TRIAL REGISTRATION NUMBER: NCT03551808., (© 2023. The Author(s).)

Published
2023
Full Text
View/download PDF

38. Risk Factors Associated with Keratoconus in an Iranian Population.

Author

Mohammad-Rabei H, Ramin S, Lotfi S, Sabbaghi H, Karimian F, Abdi S, Hasan Shahriari M, Kheiri B, Sheibani K, and Ali Javadi M

Abstract

Purpose: To determine associated factors for keratoconus (KCN) in the Iranian population., Methods: In this retrospective case-control study, 100 KCN patients and 200 age- and sex-matched individuals, who were either candidates for photorefractive keratectomy or healthy referrals from the Torfeh Eye Hospital, were included as the case and control groups, respectively. KCN patients were all registered at the Iranian National Registry of Keratoconus (KCNRegⓇ). Demographic characteristics, patients' symptoms and their habits, as well as systemic and ocular disorders were documented. Clinical examinations included best corrected visual acuity (BCVA) and refractive error measurements, biomicroscopic examination, and corneal imaging., Results: In this case group, the frequency of mild, moderate, and severe KCN was 38%, 28%, and 34%, respectively. Parental consanguinity (odds ratio [OR] = 1.758, P = 0.029), positive familial history in patients' first degree (OR = 12.533, P < 0.001) and second degree (OR = 7.52, P < 0.001) relatives, vernal keratoconjunctivitis (OR = 7.510, P = 0.003), severe eye rubbing (OR = 10.625, P < 0.001), and systemic diseases including migraine, hypertension, and thyroid disease (OR = 6.828, P = 0.021) were found as associated factors for KCN. Lesser frequency of KCN was observed in patients with Fars ethnicity (OR = 0.583, P = 0.042), with higher levels of wealth indices (OR = 0.31, P < 0.001) and higher levels of education (OR = 0.18, P = 0.024)., Conclusion: Severe eye rubbing, vernal keratoconjunctivitis, parental consanguinity and positive familial history of KCN, low socioeconomic status, and low levels of education were significantly associated with KCN in our study population., Competing Interests: The authors have no conflict of interest with the subject matter of this manuscript., (Copyright © 2023 Mohammad-Rabei et al.)

Published
2023
Full Text
View/download PDF

39. Torsion among Women with Acute Lower Abdominal Pain: A Retrospective Cross-Sectional Study.

Author

Agha Majidi M, Arab M, Ghodssi-Ghassemabadi R, Nouri B, Ghavami B, and Sheibani K

Abstract

Background: Lower abdominal or pelvic pain is a common complaint among women and one of the most challenging findings to evaluate. We performed the present study to construct a new algorithm for predicting the chance of ovarian torsion among women with acute lower abdominal pain. Methods: This diagnostic retrospective cross-sectional study was performed on all female individuals who were referred to Imam Hossein Medical Center, Tehran, Iran, with the chief complaint of acute lower abdominal pain, and underwent laparotomy between 2010 and 2016. Clinical and paraclinical findings were evaluated to construct a predictive model for ovarian torsion. The variables were compared in 2 groups. The first group included individuals with a final diagnosis of ovarian torsion and the second group included those individuals with any diagnosis other than ovarian torsion. All data were compared between these 2 groups using SPSS software Version 21 to find the related findings with a predictive value for ovarian torsion. Results: A total of 372 participants were evaluated, of whom 116 participants (31.2%) had ovarian torsion (case group) and 256 participants had other diagnoses for their lower abdominal pain (control group). Nausea and vomiting ( p < 0.001), tenderness ( p < 0.001), the size of ovarian mass ( p = 0.004), and the percentage of polymorphonuclear ( p < 0.001) showed significant relationships with ovarian torsion as the final diagnosis. Multiple logistic regression models were constructed to predict the factors affecting ovarian torsion, and a scoring system was designed to predict ovarian torsion, with a sensitivity of 77.59% (68.9%- 84.8%) and specificity of 74.61% (68.8% 79.8%). Conclusion: The proposed model is suitable for predicting ovarian torsion and its necessary information is readily available from individuals' history, examination findings, laboratory results, and an ultrasound exam., (© 2022 Iran University of Medical Sciences.)

Published
2022
Full Text
View/download PDF

40. Pretreatment with frequent topical betamethasone in Ahmed glaucoma valve implantation.

Author

Yadgari M, Vafaei F, Sobhani S, Sheibani K, and Noorizadeh F

Subjects
Betamethasone therapeutic use, Follow-Up Studies, Humans, Intraocular Pressure, Postoperative Complications surgery, Prosthesis Implantation, Retrospective Studies, Treatment Outcome, Visual Acuity, Glaucoma drug therapy, Glaucoma surgery, Glaucoma Drainage Implants
Abstract

Objective: To evaluate the efficacy of pretreatment with topical betamethasone in Ahmed glaucoma valve (AGV) implantation., Design: Randomized clinical trial., Participants: Sixty-two eyes from 62 patients undergoing AGV., Methods: We randomly assigned patients undergoing AGV to 2 arms of the study. The case group received AGV implantation with preoperative betamethasone eye drops, and the control group did not receive preoperative betamethasone. Follow-up examinations were performed on postoperative day 1, at least weekly for 4 weeks, and then every 1 to 3 months. Our main outcome measure was the rate of success, defined as intraocular pressure (IOP) <15 mm Hg and IOP ≤18 mm Hg., Results: We analyzed 62 eyes divided to case (n = 33) and control (n = 29) groups. The success rate was significantly higher in the intervention group than in the control group at 12 months postoperatively when considering either IOP < 15 or IOP < 18 mm Hg as success (p < 0.001) and also at 6 months when considering IOP < 18 mm Hg as success (p < 0.041). The reduction in the number of antiglaucoma medications used postoperatively was significantly higher in the betamethasone group at follow-up at 1 and 3 months and 1 year., Conclusion: Pretreatment with topical betamethasone in AGV implantations increases the success rate and reduces the need for medications., (Copyright © 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.)

Published
2022
Full Text
View/download PDF

41. Management of Consecutive Exotropia.

Author

Rajavi Z, Sabbaghi H, Behradfar N, Yaseri M, and Sheibani K

Abstract

Purpose: To determine the clinical characteristics and surgical outcomes of medial rectus (MR) advancement with or without lateral rectus (LR) recession in patients with consecutive exotropia., Methods: This interventional case series was performed on patients with consecutive exotropia of more than 15 prism diopters (PD) at least 6 months after the esotropia surgery. All patients were operated using either unilateral or bilateral MR muscle advancement with or without simultaneous LR recession. Ocular deviation at far and near distances, adduction limitation, and exoshift were investigated at the follow-ups of 1 week, as well as 1, 3, and 6 months after the surgery. Operation was considered successful when the postoperative far deviation was <10 PD., Results: Thirty patients were evaluated. The mean amount of MR advancement was 5.69 ± 1.33 mm with the mean dose response of 4.7 ± 3.3 and 4.55 ± 4.01 PD at 3 and 6-month follow-ups, respectively. Success rate was reduced from 93% at week 1 to 73% at month 6 due to postoperative exodrift, especially during the first 3 months. Preoperative exotropia was the only contributing factor in our study., Conclusions: MR advancement was an effective surgical method for consecutive exotropia correction, especially in cases with MR underaction. Bilateral MR advancement and/or LR recession are suggested in cases with higher preoperative exodeviation. The presence of postoperative exodrift indicates longer follow-ups for patients., Competing Interests: There are no conflicts of interest., (Copyright: © 2022 Journal of Current Ophthalmology.)

Published
2022
Full Text
View/download PDF

42. A new decision making model for diagnosing acute appendicitis among non-pregnant women and its comparison with alvarado scoring system.

Author

Arab M, Nemati Honar B, Ghavami B, Ghodssi-Ghassemabadi R, Aghaei M, Yousefi N, and Sheibani K

Abstract

Background: Although acute appendicitis is a common problem, it remains a difficult diagnosis to establish, particularly among females of reproductive age. The present study was conducted to devise a new decision making model for diagnosing acute appendicitis in non-pregnant women. Methods: The present study was a retrospective study consisting of women who had undergone an appendectomy between 2007 and 2015 at the emergency department of Imam Hossein Medical Center, Tehran, Iran. The inclusion criteria were being a female, presenting with abdominal pain, being a suspected case of acute appendicitis, and undergoing an emergency appendectomy. A classification and regression tree (CART) analysis was performed to partition exam and laboratory data obtained from these patients into homogeneous groups in order to develop a prediction rule for appendicitis diagnosis. Results: The study population included 433 non pregnant women who underwent emergency operations with a preliminary diagnosis of acute appendicis. Out of these patients, 295 patients (68.1%) were appendicitis positive based on the pathology exam results, while 138 patients had a normal appendix, indicating a negative appendectomy rate of 31.8%. The final devised CART model included hemoglobin level, PMN count, age, and history of abdominal incision and yielded a sensitivity of 82.7% and specificity of 55.8%, which were better than Alvarado prediction results for the Asian population. Conclusion: We have devised a simple and cost effective prediction model for predicting the outcome among non-pregnant women undergoing emergency appendectomy operation with good sensitivity and specificity compared to the Alvarado model., (© 2021 Iran University of Medical Sciences.)

Published
2021
Full Text
View/download PDF

43. Retinal Vascular Abnormalities in Different Types of Inherited Retinal Dystrophies Assessed by Optical Coherence Tomography Angiography.

Author

Sabbaghi H, Daftarian N, Hassanpour K, Fekri S, Nourinia R, Suri F, Kheiri B, Yaseri M, Rajabpour M, Sheibani K, and Ahmadieh H

Abstract

Purpose: To investigate the retinal vascular characteristics among patients with different types of inherited retinal dystrophies (IRDs)., Methods: This comparative cross-sectional study was conducted on 59 genetically confirmed cases of IRD including 37 patients with retinitis pigmentosa (RP) (74 eyes), 13 patients with Stargardt disease (STGD) (26 eyes), and 9 patients with cone-rod dystrophy (CRD) (18 eyes). Both eyes of 50 age- and sex-matched healthy individuals were investigated as controls. All participants underwent optical coherence tomography angiography to investigate the vascular densities (VDs) of superficial and deep capillary plexus (SCP and DCP) as well as foveal avascular zone area., Results: In RP, significantly lower VD in whole image ( P = 0.001 for DCP), fovea ( P = 0.038 for SCP), parafovea ( P < 0.001 for SCP and DCP), and perifovea ( P < 0.001 for SCP and DCP) was observed compared to controls. In STGD, VD of parafovea ( P = 0.012 for SCP and P = 0.001 for DCP) and fovea ( P = 0.016 for DCP) was significantly lower than controls. In CRD, the VD of parafovea ( P = 0.025 for DCP) was significantly lower than controls. Whole image density was significantly lower in RP compared to STGD ( P < 0.001 for SCP) and CRD ( P = 0.037 for SCP). VD in parafovea ( P = 0.005 for SCP) and perifovea ( P < 0.001 for SCP and DCP) regions was significantly lower in RP compared with STGD. Also, foveal VD in STGD was significantly lower than RP ( P = 0.023 for DCP)., Conclusion: Our study demonstrated lower VDs in three different IRDs including RP, STGD, and CRD compared to healthy controls. Changes were more dominant in RP patients., Competing Interests: There are no conflicts of interest., (Copyright: © 2021 Journal of Current Ophthalmology.)

Published
2021
Full Text
View/download PDF

44. Lateral rectus resection versus lateral rectus plication in patients with residual Esotropia.

Author

Rajavi Z, Sabbaghi H, Kheiri B, and Sheibani K

Subjects
Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Postoperative Period, Reoperation, Retrospective Studies, Treatment Outcome, Vision, Binocular physiology, Esotropia surgery, Oculomotor Muscles surgery, Ophthalmologic Surgical Procedures methods
Abstract

This study was aimed to compare the surgical outcomes of lateral rectus plication and resection techniques on patients with residual esotropia. In this randomized clinical trial, a total of 57 patients with residual esotropia (31 females) who were candidates for lateral rectus resection were randomized into plication (n = 27) and resection (n = 30) groups. The inclusion criteria were residual Esotropia after uni- or bilateral medial rectus recession. Subjects with a history of prematurity, lack of central fixation, extraocular muscle palsy, systemic, ocular disorders, history of lateral rectus operation, or follow up less than 3 months were excluded. Ophthalmic examinations were conducted preoperatively and at 1, 3-, and 6-month follow-ups. Surgical success rate was considered postoperative eso- or exotropia ≤10 pd. Based on the study results, there was no statistically significant difference between the two groups regarding the pre- (plication: 27.9 ± 9.8 pd and resection: 26.4 ± 7.6 pd; P = .52) and postoperative mean angle of deviation at far distance in month 3 (plication: 5.1 ± 7.1 pd and resection: 5.4 ± 3.2 pd; P = .82). Postoperative success rate also showed similarity between these two groups at all postoperative follow-ups of months 1, 3, and 6.There was no statistically significant difference between dose responses of these groups in uni- or bilateral operations. In conclusion, lateral rectus plication and resection showed statistically similar results. Each surgical method could be selected according to surgeon's skill and comfort. We recommend plication method for patients with postoperative probability of anterior segment ischemia.

Published
2020
Full Text
View/download PDF

45. Motor and Sensory Outcomes of Infantile Exotropia: A 10-Year Study (2008-2017).

Author

Rajavi Z, Sabbaghi H, Behradfar N, Abdi S, Bahraini R, Kheiri B, and Sheibani K

Subjects
Adolescent, Adult, Child, Child, Preschool, Exotropia physiopathology, Female, Follow-Up Studies, Humans, Male, Oculomotor Muscles physiopathology, Retrospective Studies, Young Adult, Exotropia surgery, Eye Movements physiology, Forecasting, Oculomotor Muscles surgery, Ophthalmologic Surgical Procedures methods, Vision, Binocular physiology, Visual Acuity
Abstract

Purpose: We aimed to determine the long-term motor and sensory outcomes of patients with infantile exotropia., Methods: In this longitudinal retrospective (historical cohort) study, the records of 76 patients with infantile exotropia were Studied. Subjects with constant exotropia manifesting before the age of 1 year who were at least 5 years old at recruitment time between 2008 and 2017 were included., Results: The medical records of 26 patients were excluded due to not participating in follow-up examinations or having incomplete records. In total, 54 infantile exotropic patients (51.9% male) with a mean age of 11.1 ± 6.8 years and follow-up of 4.99 ± 3.58 years were studied. Postoperative sensory outcomes (central stereopsis [<60 sec/arc], peripheral fusion [60-3,000 sec/arc], and non-stereopsis [>3,000 sec/arc]) were observed in 38.9%, 38.9%, and 21.2% of patients, respectively. In terms of postoperative motor outcomes, 69%, 24%, and 7% were achieved as orthophoria, residual exotropia, and consecutive esotropia, respectively. Patients with a higher surgical age ( p = 0.022) and better visual acuity ( p = 0.004) had significantly better sensory outcomes, while higher preoperative deviation resulted in more suppression ( p = 0.039, rs = 0.218)., Conclusions: With rates of 69% for motor success and 78.8% for sensory success, surgical outcomes of infantile exotropic patients seems to be favorable. Further studies are recommended to verify our findings., Competing Interests: No potential conflict of interest relevant to this article was reported., (© 2020 The Korean Ophthalmological Society.)

Published
2020
Full Text
View/download PDF

46. The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial.

Author

Akbari Sene A, Tabatabaie A, Nikniaz H, Alizadeh A, Sheibani K, Mortezapour Alisaraie M, Tabatabaie M, Ashrafi M, and Amjadi F

Subjects
Adult, Double-Blind Method, Female, Fertilization in Vitro, Folic Acid pharmacology, Humans, Inositol pharmacology, Oocytes pathology, Polycystic Ovary Syndrome pathology, Folic Acid therapeutic use, Infertility, Female therapy, Inositol therapeutic use, Oocytes drug effects, Polycystic Ovary Syndrome drug therapy, Reproductive Techniques, Assisted standards
Abstract

Purpose: The aim of the present study was to evaluate the effect of myo-Inositol administration on oocyte quality, fertilization rate and embryo quality in patients with PCOS during assisted reproductive technology (ART) cycles., Methods: Fifty infertile PCOS patients were randomly designated in two groups. In the study group, patients received daily doses of 4 g myo-Inositol combined with 400 mg folic acid and in the control group patients received only 400 mg folic acid from 1 month before starting the antagonist cycle until the day of ovum pick up. Oocyte and embryo qualities were assessed according to European Society of Human Reproduction and Embryology (ESHRE) guidelines. The gene expression of PGK1, RGS2 and CDC42 as a factor of oocyte quality in granulosa cells was analyzed using real-time RT-PCR. Levels of total antioxidant capacity (TAC) and reactive oxygen species (ROS) were evaluated by chemiluminescence assay in follicular fluid., Results: The percentage of metaphase II oocyte, fertilization rate and embryo quality significantly improved in the study group (p < 0.05), but the number of retrieved oocytes and follicle count were not statistically different between groups. Furthermore, the gene expression of PGK1, RGS2 and CDC42 was significantly higher in the study group (p < 0.05) but no differences were found between two groups in terms of TAC and ROS levels., Conclusions: The present study findings suggest that myo-Inositol alters the gene expression in granulosa cells and improves oocyte and embryo quality among PCOS patients undergoing ART.

Published
2019
Full Text
View/download PDF

47. Comparing the results of intradiscal ozone injection to treat different types of intervertebral disc herniation based on MSU classification.

Author

Hosseini B, Taheri M, and Sheibani K

Subjects
Adult, Disability Evaluation, Female, Humans, Intervertebral Disc Displacement diagnostic imaging, Magnetic Resonance Imaging, Male, Ozone administration & dosage, Pain Management, Pain Measurement, Patient Selection, Treatment Outcome, Intervertebral Disc Displacement classification, Intervertebral Disc Displacement drug therapy, Ozone therapeutic use
Abstract

Purpose: To evaluate the therapeutic efficacy of intradiscal ozone injection in reducing pain and improving patients' performance in different types of intervertebral disc herniation based on Michigan State University (MSU) classification., Patients and Methods: Consecutive patients with low back pain and radiculopathy treated in our center with ozone chemonucleolysis from May 2017 through to January 2018 entered the study. Patients had a disc herniation classified as group 1-A, 2-A, 1-B, 2-B, 1-C, 2-C, 1-AB or 2-AB based on MSU classification in magnetic resonance imaging. In all patients entering the study the severity of pain was recorded according to the visual analog scale criteria before and one and three months after the end of treatment. Oswestry Low Back Pain Disability Index (ODI) was used to compare patients' performance before and after the treatment., Results: In total 128 patients (60 females and 68 males) with mean age of 40.1 ± 10.7 entered the study. The patients were divided into eight groups based on MSU classification each including 16 patients. The reduction of pain severity and ODI score compared to baseline was statistically significant in all groups both in the first month and the third month after treatment. There was also a statistically significant difference between groups regarding the reduction of pain and ODI score indicating significantly worse treatment outcomes in groups 1-C, 2-C and 2-AB., Conclusion: Based on our findings it seems that MSU classification can be used in patients' selection to achieve the best treatment outcome after intradiscal ozone injection among patients with lumbar disc herniation.

Published
2019
Full Text
View/download PDF

48. Comparative Assessment of Tear Function Tests, Tear Osmolarity, and Conjunctival Impression Cytology between Patients with Pterygium and Healthy Eyes.

Author

Safarzadeh M, Heidari S, Azizzadeh P, Sheibani K, Nassiri N, Heidari L, and Aghataheri S

Abstract

Purpose: To compare histologic abnormalities of tear film and tear osmolarity between normal eyes and eyes with pterygium., Methods: This was a prospective, hospital-based, case-control study involving 95 patients (65 men, 30 women) with unilateral pterygium. The tear meniscus height (TMH), Schirmer's test-1 (SCH-1) score, Rose Bengal staining (RBS) score, tear film breakup time (TBUT), tear osmolarity (TO), and conjunctival impression cytology (CIC) were assessed in both eyes. The Chi-square and Student's t -tests were used to compare the results between the two groups. P values <0.05 were considered statistically significant., Results: The mean patient age was 50.9 years, with the largest age group being the 45-55 year-old bracket across both genders. Most patients (82.1%) had nasal pterygium, and 80% were involved in outside activities. The mean assessment values in the case and control groups were as follows: TMH, 0.21 vs. 0.24 mm; SCH-1, 13.2 vs. 17.8 mm; RBS, 4.38 vs. 2.51 points; TBUT, 8.7 vs. 13.2 seconds; TO, 306 vs. 299 mOsm/L ( P < 0.001 in all cases). The proportions of abnormal assessment values in the case and control groups were as follows: TMH, 82.1% vs. 3.16%; SCH-1, 20% vs. 2.1%; RBS, 30.53% vs. 4.22%; TBUT, 61.05% vs. 6.3%; TO, 10.52% vs. 1.05%; CIC, 33.7% vs. 7.37% ( P < 0.05 for all comparisons)., Conclusion: This study showed that the quantity and quality of tear film, as well as the number of goblet cells, decreased, but the tear osmolarity increased in eyes with pterygium. Furthermore, the TMH, RBS results, TBUT, and CIC have more precise state of the patient's tear condition with the disease of the pterygium., Competing Interests: There are no conflicts of interest.

Published
2019
Full Text
View/download PDF

49. The relationship between abduction deficit and reoperation among patients with infantile esotropia.

Author

Rajavi Z, Sabbaghi H, Torkian P, Behradfar N, Yaseri M, Feizi M, Faghihi M, and Sheibani K

Abstract

Aim: To determine the relationship between abduction deficit and reoperation among patients with infantile esotropia (IET)., Methods: The records of 216 patients (432 eyes) with IET who underwent surgery, from 2010 to 2015 were studied. Patients with IET whose deviation appeared before 6mo of age and had stable preoperative deviation in two examinations with at least 2wk apart and a minimum 3mo postoperative follow up were included. Cases with early onset accommodative esotropia, congenital cataract, retinopathy of prematurity (ROP), manifest nystagmus, fundus lesions, neurologic and ophthalmic anomalies, 6 th nerve palsy and Duane's syndrome were excluded. Preoperative abduction deficit was considered from -1 to -3 grading scale. Three months after surgery, children were classified into no-need reoperation [deviation≤15 prism diopters (PD)], and need-reoperation groups (deviation>15 PD)., Results: In this retrospective study, 117 female and 99 male patients with the mean surgical age of 4.7±6.4y were included. Reoperation rate was 33.3% and 16.0% in IET patients with and without abduction deficit, respectively in patients who had a history of late surgery. Abduction deficit increased the odds of reoperation by 82% [OR=1.82, 95% confidence interval (CI) =1.05 to 3.19, P =0.003] in patients who had a history of late surgery (>2 years old, P =0.021). Abduction deficit was improved significantly after operation ( P <0.001)., Conclusion: Based on our results, abduction deficit can be considered as a risk factor of reoperation in IET patients who are operated at the age of more than 2y.

Published
2018
Full Text
View/download PDF

50. Vitamin B12 Deficiency as a Cause of Neurotrophic Keratopathy.

Author

Nassiri N, Assarzadegan F, Shahriari M, Norouzi H, Kavousnezhad S, Nassiri N, and Sheibani K

Abstract

Introduction: Neurotrophic keratitis is a rare degenerative corneal disease caused by an impairment of trigeminal corneal innervation, leading to a decrease or absence of corneal sensation. Here, we present a case of neurotrophic keratopathy caused by B12 deficiency in a 34 years old man who had a progressive decrease in visual acuity and corneal involvement since 3 months before being referred to our ophthalmology clinic., Result and Discussion: Based on our clinical findings and with the diagnosis of B12 deficiency we started B12 treatment for the patient. After 3 weeks the patient showed a dramatic response with corneal sensation reversal, an increase of visual acuity, improved neurotrophic keratopathy and significantly improved neurological findings. To the best of our knowledge, there is no report regarding vitamin B12 deficiency induced keratopathy and this is the first report that describes this aspect of vitamin B12 deficiency.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results